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Age-related macular degeneration 
(AMD) is the most common reason 
for visual impairment in western 
countries. Retinal pigment epithelial 
cells (RPE) and extra- and intracellu-
lar protein aggregation play a crucial 
role in the development of this dis-
ease. The main focus of this study 
was the formation of protein aggre-
gates and their removal in RPE cells. 
This thesis contributes to the overall 
knowledge on the function of RPE 
cells and provides a new possible 
target for designing novel therapies 
against AMD.
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ABSTRACT 
 
Age-related macular degeneration (AMD) is a progressive neurodegenerative eye-disease 
that is the most common reason for visual impairment in western countries. The number of 
people suffering from AMD is constantly growing. Currently, there is no treatment 
available for the vast majority of AMD patients and the pathological mechanisms at the 
molecular level are not well understood. Retinal pigment epithelial cells (RPE) and different 
extra- and intracellular protein aggregates play a significant role in the development of this 
disease. Several beneficial and protective cellular systems, such as heat shock protein (Hsp) 
response and proteolysis, deteriorate in aged RPE cells. In time, this leads to degeneration 
in photoreceptors and subsequently to severe difficulties in vision. 
In the present series of studies, lipid peroxidation product 4-hydroxy-2-nonenal (HNE)-
induced oxidative stress was first studied with Hsp70 inducer (Hsp90 inhibitor), followed 
by the characterisation of two different Hsp90 inhibitors. Subsequently, protein aggregation 
and its possible removal processes and their links to Hsp70 were examined. In the fourth 
study, the roles of Hsp90, microtubule network and its acetylation were assessed in the 
formation and degradation of protein aggregates. All studies were conducted with a 
human RPE cell line (ARPE-19). 
Hsp70 and Hsp90 are involved in the regulation of HNE-induced oxidative stress 
reaction. Although the Hsp90 inhibitor increased the level of Hsp70 significantly, it 
potentiated the HNE-induced cell death. Interestingly, the non-quinone Hsp90 inhibitor, 
radicicol, induced more oxidative stress than the quinone geldanamycin, and furthermore 
geldanamycin was found to be more toxic. Proteasome inhibitor-induced protein 
aggregates were demonstrated to be lysosomal and positive for Hsp70 and ubiquitin. 
Hsp70 and especially Hsp90 were shown to regulate the formation of protein aggregates 
with the microtubule network playing an important role. It seems that at least non-
senescent RPE cells have the capacity to degrade protein aggregates. This was observed to 
occur via autophagic degradation and it appears that molecular chaperone Hsp70 is 
involved in this process. 
In conclusion, these findings clarify the protein aggregation process in RPE cells. In 
addition, the already known significant role of Hsps in cellular survival was amplified. The 
results presented in this dissertation contribute to the overall knowledge on the function of 
RPE cells and provide a new target for designing novel therapies against AMD and other 
age-related degenerative protein aggregation diseases. 
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TIIVISTELMÄ 
 
Silmänpohjan ikärappeuma on yleisin näkövammaisuuden syy länsimaissa. Väestön 
ikääntyessä ikärappeumasta kärsivien määrä kasvaa koko ajan. Tällä hetkellä suurimmalle 
osalle ikärappeumapotilaista ei ole tarjolla minkäänlaisia hoitomahdollisuuksia. 
Ikärappeuman patologiset mekanismit molekyylitasolla ovat vielä hämärän peitossa. 
Verkkokalvon pigmenttiepiteelisolut (RPE) ja erilaiset solujen sisälle sekä ulkopuolelle 
kasaantuvat proteiinikertymät ovat keskeisessä asemassa taudin synnyssä. Monet soluja 
suojaavat koneistot, kuten lämpöshokkiproteiinit ja proteolyyttiset mekanismit, 
heikkenevät iän myötä RPE-soluissa, mikä johtaa vähitellen valoaistinsolujen 
rappeutumiseen ja lopulta vakaviin ongelmiin näkökyvyssä. 
Tässä tutkimusten sarjassa ensimmäisenä tarkasteltiin lipidiperoksidaation lopputuotteen 
(4-hydroksi-2-nonenaali, HNE) aiheuttamaa solustressiä yhdessä Hsp70:n tasojen nostajan 
(Hsp90 inhibiittori) kanssa, jonka jälkeen keskityttiin kahden eri Hsp90-inhibiittorin 
karakterisointiin. Kolmannen tutkimuksen aiheena oli proteiinien aggregaatio, 
proteiinikertymien mahdolliset poistamismekanismit sekä näiden yhteys Hsp70:een. 
Viimeisessä tutkimuksessa Hsp90:n ja mikrotubulusverkoston ja sen asetylaation 
merkitystä arvioitiin proteiiniaggregaatttien muodostumisessa ja hävittämisessä. Kaikki 
tutkimukset tehtiin verkkokalvon pigmenttiepiteelisolulinjalla (ARPE-19). 
Hsp70 ja Hsp90 näyttäisivät osallistuvan HNE:llä aiheutetun oksidatiivisen stressin 
säätelyyn. Vaikka Hsp90-inhibiittori nosti Hsp70:n määrää merkittävästi, se lisäsi silti 
HNE:n aiheuttamaa solukuolemaa. Hsp90-inhibiittori, jolla ei ole kinonirakennetta 
(radicicol), aiheutti suuremman oksidatiivisen stressin kuin kinonirakenteinen 
geldanamysiini. Tästä huolimatta geldanamysiini oli kokonaisuudessaan toksisempi. 
Proteasomi-inhibiittorin aiheuttamat proteiiniaggregaatit todistettiin olevan lysosomaalisia 
sekä Hsp70- ja ubikitiinipositiivisia. Hsp70:n ja Hsp90:n osoitettiin säätelevän proteiinien 
aggregaatiota. Tämän lisäksi mikrotubulusverkostolla on osansa proteiinikertymien 
synnyssä. Nuorten RPE-solujen osoitettiin pystyvän poistamaan proteiinikertymiä 
tehokkaasti autofagisen hajotuksen avulla, jonka säätelyyn Hsp70 näyttäisi osallistuvan.  
Yhteenvetona voidaan todeta, että nämä löydökset auttavat ymmärtämään paremmin 
RPE-soluissa tapahtuvaa proteiinien kertymistä. Tämän lisäksi käsitys 
lämpöshokkiproteiinien tärkeästä roolista solujen hyvinvoinnissa vahvistui ja selkiytyi 
entisestään. Tutkimuksen tulokset lisäävät tietoa RPE-solujen toiminnasta ja tarjoavat 
uuden kohteen hoitomuotojen kehittelyssä silmänpohjan ikärappeumaa ja muita 
ikääntymiseen liittyviä proteiinikertymäsairauksia vastaan. 
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1 Introduction 
Age-related macular degeneration (AMD) is responsible for approximately two out of 
every three cases of visual impairment in the elderly in the western world. Globally, it is 
estimated that there are 50 million people that suffer from AMD and more or less one 
third of them are virtually blind (Gehrs et al. 2006, Resnikoff et al. 2004). The disease is 
becoming more and more prevalent as a consequence of the increasing aging of 
population; the number of AMD patients is expected to double or even triple during the 
next decades (Rein et al. 2009). In addition to complete blindness, AMD causes shadows, 
blind spots, blurriness and distortion in the area of central vision. These eventually lead to 
troubles in reading, recognising faces or even walking (Jager, Mieler & Miller 2008, Noble, 
Chaudhary 2010). For about 80 % of AMD patients, there are no treatment possibilities 
available, and even those that are available only slow down the inexorable progress of the 
disease (Prasad, Schwartz & Hubschman 2010). 
 
AMD is a disease of the macula, the area of the retina responsible for acute and colour 
vision. In the macula, the photoreceptors can suffer from different kind of damages for 
many reasons (Chakravarthy, Evans & Rosenfeld 2010). In these processes, the retinal 
pigment epithelial (RPE) cells play a crucial role. These post-mitotic cells take care of the 
well-being of the photoreceptors, for example by trafficking a variety of molecules and 
degrading toxic waste products from them (Sparrow, Hicks & Hamel 2010). The 
degeneration of RPE cells ultimately leads to diminished function and reduced viability of 
the photoreceptors which in turn impairs vision. Therefore, RPE cells are one of the most 
interesting therapeutic targets to prevent secondary effects which are detrimental to the 
retina (Kaarniranta et al. 2010, Sparrow, Hicks & Hamel 2010, Vaajasaari et al. 2011). 
 
Oxidative stress is one of the reasons for cellular senescence (Romano et al. 2010). This is 
especially true for RPE cells exposed to an extreme oxidative stress due to their function 
and location (Beatty et al. 2000). In senescent RPE cells, many beneficial, protective cellular 
mechanisms, such as the heat shock protein response and proteolysis become impaired. 
This leads to formation of intracellular and extracellular protein aggregates, i.e. lipofuscin 
and drusen respectively, and furthermore to inflammation (Anderson et al. 2002, Gehrs et 
al. 2006). Heat shock proteins, impaired proteolysis and protein aggregation have been 
identified as important factors also in many other age-related degenerative diseases 
(Aguzzi, O'Connor 2010, Ali, Kitay & Zhai 2010, Meriin, Sherman 2005).  
 
Retinal intra- and extracellular protein aggregation is clearly linked to AMD (Kaarniranta 
et al. 2009, Kaarniranta et al. 2010). The mechanisms behind this protein aggregation and 
their exact associations to AMD are not yet fully understood. It is believed that by 
removing or inhibiting the formation of these protein aggregates, it may be possible to 
2 
 
prevent the onset or at least slow down the progression of AMD. In this study, oxidative 
stress, heat shock protein response and protein aggregation were examined in RPE-cells 
(ARPE-19). 
3 
 
2 Review of the Literature 
2.1 AGE-RELATED MACULAR DEGENERATION (AMD) 
2.1.1 Prevalence of AMD 
AMD is a severe eye disease; according to WHO, it is the third most common reason for 
visual impairment throughout the world, after cataract and glaucoma (Resnikoff et al. 
2004). If one confines the estimate to only western countries, then AMD becomes the 
number one cause of visual impairment (Bunce, Wormald 2006, Congdon et al. 2004, 
Wang, Foran & Mitchell 2000). The disease affects mainly individuals older than 55 years 
(Klein et al. 2010) making it the leading cause of vision loss among the elderly (Quillen 
1999). Since the life expectancy is continuously rising all over the world, the number of 
individuals suffering from AMD is becoming larger and larger. It is estimated that the 
number of people suffering from AMD will more than double by the year 2050 (Rein et al. 
2009). The prevalence of AMD is somewhat similar in white and Asian populations 
(Kawasaki et al. 2010) whereas in black population it is lower (Bressler et al. 2008, 
Friedman et al. 1999). There are approximately 50 million AMD patients worldwide out of 
whom 14 million are blind or severely visually impaired (Gehrs et al. 2006, Resnikoff et al. 
2004). 
2.1.2 Symptoms and pathology of AMD 
The progression of AMD is often slow and painless. However, in some cases, the onset can 
be rapid. In addition to complete blindness, AMD inflicts different grades of visual 
impairment. The early clinical outcome is usually shadowy areas in the central vision. As 
the disease progresses, the vision becomes blurred and distorted. Furthermore, blind spots 
appear in the middle of the visual field (Jager, Mieler & Miller 2008, Noble, Chaudhary 
2010). These detrimental changes may disable the patient rather severely; eventually it 
may become impossible to read, recognise faces, drive a car or even walk. 
 
As the name implies, AMD affects the macula, the highly specialised region of the retina 
responsible for acute and colour vision. The cellular and histological changes of this 
complex disorder occur in the outer retina, i.e. in photoreceptors (rods and cones), RPE 
cells and Bruch's membrane, and in the capillary layer of the choroid (de Jong 2006). The 
outer retina is exposed to chronic oxidative stress for many reasons (Beatty et al. 2000). 
When combined with senescence, this eventually leads to accumulation of protein 
aggregates; intracellular lipofuscin and extracellular drusen, and further on to 
inflammation (Anderson et al. 2002, Gehrs et al. 2006). In addition, new choriocapillaries 
can be formed and these can leak blood and cause harm. All these cumulative detrimental 
stressors and changes may lead to the formation of AMD (Chakravarthy, Evans & 
Rosenfeld 2010). 
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The first signs of AMD are the accumulation of few medium sized drusen in-between the 
RPE cells and Bruch’s membrane, and abnormal pigmentation of the macula. At this point, 
the disease is classified as an early form and there are no signs of visual impairment (de 
Jong 2006). When there is at least one large druse present in addition to many medium 
sized ones or there is geographic atrophy (extensive atrophy of the RPE cells and onward 
to the photoreceptors) that does not extend to the centre of the macula, the grade of AMD 
is intermediate (Jager, Mieler & Miller 2008). The late or advanced form of AMD, where 
severe vision impairment is common, is classified further into atrophic (also called dry or 
non-neovascular/non-exudative) and exudative (wet or neovascular) forms. Atrophic 
AMD is characterised by geographic atrophy in the macula, whereas exudative AMD 
involves choroidal neovascularisation (Chakravarthy, Evans & Rosenfeld 2010). The vast 
majority (80 %) of AMD patients suffer from the atrophic form of the disease. However, 
the exudative form of AMD is responsible for 90 % significant visual loss due to this 
disease (Bressler, Bressler & Fine 1988). 
 
AMD is a multifactorial disease (Fig. 1). Many genetic and environmental risk factors have 
been identified (Prasad, Schwartz & Hubschman 2010). It has been proven that three out of 
every four AMD cases can be explained by genetic abnormalities in three genes involved 
in immune regulation; complement factors H, B and complement component 2 (Edwards 
et al. 2005, Gold et al. 2006, Hageman et al. 2005, Haines et al. 2005, Klein et al. 2005). 
Smoking is the second highest environmental risk factor after aging which can be viewed 
as an unavoidable risk. Smokers carry twice the risk of developing AMD compared to 
non-smokers. Furthermore, the risk is multiplied if both smoking and high-risk genotype 
are present (Jager, Mieler & Miller 2008). Other environmental risk factors include obesity, 
high dietary intake of fat, low intake of antioxidants (Jager, Mieler & Miller 2008) and high 
blood pressure (DellaCroce, Vitale 2008). 
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Figure 1. Age-related macular degeneration is a multifactorial disease, in which the 
degeneration of retinal pigment epithelial cells (RPE) plays an essential role. The scheme is 
modified from Kaarniranta et al. (2010). 
2.1.3 Treatment and prevention of AMD 
Currently, there are no therapeutic possibilities for treating atrophic AMD (Chakravarthy, 
Evans & Rosenfeld 2010). Treatments are available for the exudative form but these only 
slow down the progression of the disease. With photodynamic therapy, the newly formed 
choroidal vessels are destroyed with the combination of laser and a photo-sensitiser 
(verteporfin). In addition, three biological medicines can be used to inhibit the 
neovascularisation; an aptamer against vascular endothelial growth factor (VEGF), 
pegaptanib, and a two recombinant anti-VEGF antibodies, ranibizumab and bevacizumab 
(Prasad, Schwartz & Hubschman 2010). However, the usage of pegaptanib is rare in clinics 
today for its weak treatment response, while ranibizumab and bevacizumab remains the 
preferred therapy against exudative AMD (Chiang, Regillo 2011). With surgical 
treatments, the benefits have been rather minimal - an exception being the treatment of 
special cases where a massive sub-retinal haemorrhage has suddenly impaired otherwise 
good vision (Prasad, Schwartz & Hubschman 2010). 
 
Since AMD cannot be cured and the treatment possibilities available are very limited, it 
would be very important to identify a preventive strategy. Indeed, preventive means have 
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been under investigation in numerous studies recently. Barker (2010) and Krishnadev et 
al. (2010) have reviewed the role of dietary supplements in the prevention of AMD. They 
concluded that carotenoids (e.g. lutein and zeaxanthin), B vitamins and ω-3 fatty acids 
could slow the progression of AMD. The increased intake of carotenoids is likely to 
improve the macular pigmentation, which in turn absorbs the damaging shorter 
wavelengths of light more efficiently. In addition, many carotenoids have beneficial 
antioxidant properties. Vitamins B6 and B12 together with folic acid reduce homocysteine 
levels. This is viewed as one of the possible ways through which they decrease the risk of 
developing AMD. An increase in dietary ω-3 fatty acids decreases the oxidative, 
inflammatory and age-related stressors in the retina (Kaarniranta, Salminen 2009). In spite 
of these promising results, more information is needed before one can introduce 
recommendations on nutritional supplements for prevention or retardation of the progress 
of AMD. Overall, a healthy diet as part of a healthy lifestyle seems to play a crucial part in 
the prevention of this disease. 
2.2 RETINA AND RPE CELLS 
The retina acts as a projection screen in the eye. This multi-layered light-sensitive tissue is 
a combination of different specialised cells (Fig. 2). The photoreceptors (rods and cones) 
are the cells that are mainly responsible for phototransduction, i.e. they convert the light 
information into electrical signals, and pass the signal to bipolar cells, via neurotransmitter 
glutamate (Young, Wheater 2006). Different light intensities and wavelengths evoke 
different grades of signals in photoreceptors. Retinal bipolar cells transmit the signals, 
with or without the help of horizontal and amacrine cells, to the retinal ganglion cells. 
Bipolar, horizontal and amacrine cells are involved in the formation of receptive fields 
which greatly improves the recognition of contrasts. Retinal ganglion cells transmit the 
visual signal to the brain (Bear, Connors & Paradiso 2007). 
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Figure 2. Schematic presentation of the retina and retinal layers. 
 
Immediately below the neurosensory retina is a post-mitotic monolayer of RPE cells. They 
can be thought of as maintenance cells for the photoreceptors. In addition, the RPE cells 
have many functions that are very important for the well-being of the whole retina 
(Sparrow, Hicks & Hamel 2010). Pigmented cells absorb harmful light energy and protect 
the structures below. Through both active and passive transport, the RPE cells, with the 
help of the Bruch’s membrane, take care of the transfer of nutrients, metabolites, ions, 
water and oxygen between the choriocapillaris below and the photoreceptors above. RPE 
cells have also phagocytic abilities (Irschick et al. 2004, Petrovski et al. 2011, Sparrow, 
Hicks & Hamel 2010); in response to constant renewal of photoreceptor outer segment 
(POS), the non-functional tips are shed from photoreceptors and phagocyted by RPE cells. 
The tight junctions between RPE cells play a crucial role in the blood-retinal barrier, which 
protects the retina from xenobiotics and other polar compounds (Steinberg 1985). The RPE 
cells are considered to play an essential part in the development of AMD (Holz et al. 2004, 
Roth, Bindewald & Holz 2004, Zarbin 2004). 
2.2.1 ARPE-19 cell line 
ARPE is derived from words human Adult Retinal Pigment Epithelial cells. The ARPE-19 
cell line spontaneously arose (i.e. not intentionally immortalised) from the primary cells of 
19-year-old male donor who died in 1986. Although, these cells are spontaneously 
transformed and therefore cannot exactly be the same as RPE cells that grow in the living 
eye, they still do posses many common characteristics with primary RPE cells (Alge et al. 
2006, Dunn et al. 1996, Dunn et al. 1998, Finnemann et al. 1997). ARPE-19 cell line seems to 
be the closest RPE cell line to the primary RPE cells (Alge et al. 2006, Mannermaa et al. 
2009). This probably is the reason for ARPE-19 being the most popular human RPE cell 
line in the world, based on PubMed publications. 
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2.3 OXIDATIVE STRESS AND RPE 
Although oxygen is essential for the survival of mammalian cells, it can also be toxic. 
Oxidative stress is a state where the production or the amount of oxidising species is 
significantly increased or the defensive antioxidative capacity has become reduced. In the 
oxidation process, reactive oxygen species (ROSs), such as free radicals and peroxides, 
take electrons from the target molecules. This can cause toxicity and damage of critical 
cellular components, e.g. DNA, proteins and lipids (Finkel, Holbrook 2000). Oxidative 
stress-induced damage is believed to have an important role in the senescence of cells 
(Romano et al. 2010). It is also linked to many diseases in humans including Alzheimer’s 
and Parkinson’s disease, atherosclerosis as well as AMD (Gella, Durany 2009, 
Khandhadia, Lotery 2010, Lakshmi et al. 2009, Zhou, Huang & Przedborski 2008). 
 
The retina is an ideal place for the formation of ROSs for several reasons. It consumes 
more oxygen than any other tissue, and the choroidal blood flow is the highest of any 
tissue in the body. The light exposure through the pupil induces oxidative damage. 
Neuronal retina and RPE cells contain light-absorbing molecules, photosensitisers, which 
worsen the situation even more. The POS in the retina contains an abundance of already 
oxidised polyunsaturated fatty acids. Phagocytosis of the POS by the RPE cells produces 
free radicals (Beatty et al. 2000). The high metabolic activity in the retina is another reason 
for the production of oxidising agents (Khandhadia, Lotery 2010). In addition to the high 
level of oxidative damage, the RPE cells and the retina are also very vulnerable to toxicant-
induced damage for a variety of reasons (Casarett, Klaassen 2008). 
2.4 HEAT SHOCK PROTEINS (HSPS) 
Several biochemical changes occur in cells when they are exposed to various types of 
stress. In contrast to many other genes, the transcription of Hsps is upregulated. The Hsps 
are present in all cells; eukaryotic as well as prokaryotic and plant cells (Morimoto 1998). 
They are also one of the best conserved proteins throughout evolution (Richter, Haslbeck 
& Buchner 2010). These facts clearly highlight their importance for cellular well-being. 
Heat is not the only stress stimulus that induces Hsps; many environmental stressors (e.g. 
ROSs and heavy metals), pathophysiological states (e.g. inflammation, injury and 
ischemia), normal physiological functions (e.g. proliferation and differentiation) and 
changes in protein conformations (e.g. aging and cancer) greatly increase the expression of 
Hsps (Morimoto 2008). Hsps are divided into families according to their molecular 
weights. Many Hsps are expressed constitutively and have a housekeeping role, whereas 
the inducible Hsps are intended to offer protection against cellular damage and to help in 
the recovery during stressful conditions (Kalmar, Greensmith 2009, Richter, Haslbeck & 
Buchner 2010, Turturici, Sconzo & Geraci 2011). Hsps are associated with many 
neurodegenerative diseases, as well as with AMD (Ali, Kitay & Zhai 2010, Meriin, 
Sherman 2005, Sajjad, Samson & Wyttenbach 2010, Tutar, Tutar 2010). Elevated levels of 
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some Hsps have been observed in the retinas of AMD patients (Decanini et al. 2007, 
Kaarniranta et al. 2009). 
 
Cellular homeostasis is largely dependent on the quality control of proteins, proteostasis. 
This is a complex set of processes including synthesis, folding, translocation and 
degradation of proteins. Hsps have an essential role in these processes (Morimoto 2008, 
Roth et al. 2008). One of the key functions of Hsps is to act as molecular chaperones 
(Vabulas et al. 2010). All functional proteins have their distinctive tertiary and quaternary 
structures. These three-dimensional structures are often altered in response to different 
stresses; the protein may start to expose its hydrophobic parts, which are normally hidden 
inside of the protein, and these are likely to bind and aggregate, resulting in an 
inappropriately folded protein (Pierpaoli 2005). Molecular chaperones try to restore the 
correct structure of misfolded proteins and also help to ensure the proper folding of newly 
formed proteins. In addition, Hsps also prevent the accumulation of harmful protein 
aggregates (Saibil 2008, Vabulas et al. 2010). Misfolded proteins and protein aggregates 
represent a major burden within cells (Taipale, Jarosz & Lindquist 2010) and are linked to 
several pathological states, such as cardiovascular, oncological, and neurodegenerative 
disorders (Balch et al. 2008). Hsp70 and Hsp90 are the major chaperones in proteostasis 
(Pratt et al. 2010). Hsps also play an important part in the so-called protein triage; they 
facilitate the degradation of proteins through the ubiquitin-proteasome pathway (Lanneau 
et al. 2010, Pratt et al. 2010). 
 
Hsps promote cellular survival also by inhibiting apoptosis through several mechanisms 
(Beere 2004, Parcellier et al. 2003). Some extracellular and membrane-bound Hsps, 
especially Hsp70, take part in the immune defence (Nishikawa, Takemoto & Takakura 
2008). Hsp90 promotes the maintenance of the length of DNA telomeres by supporting the 
active telomerase enzyme, whereas Hsp70 has been shown to bind to the inactive 
telomerase, pointing to an assistive role in telomerase protein folding (DeZwaan, Freeman 
2010, Forsythe et al. 2001). 
2.4.1 Hsp70 
The most common stress inducible heat shock protein is Hsp70 (Pierpaoli 2005). The 
family it belongs to contains many different proteins (at least eight in mammalian species), 
coded by many genes located in different chromosomes. The size of Hsp70 proteins varies 
from 66 to 78 kDa (Tavaria et al. 1996). Stress inducible Hsp70 (mainly Hsp70-1a and 
Hsp70-1b, over 99 % homology) is found in the cytosol and nucleus, where almost all 
constitutively expressed Hsps (e.g. Hsc70) are localised as well (except for glucose-
regulated protein 78, Grp78 in endoplasmic reticulum and Grp75 in mitochondria) 
(Daugaard, Rohde & Jaattela 2007). 
 
Hsp70 consists of two major functional domains (Fig. 3); the amino-terminal domain that 
possesses ATP/ADP binding site as well as the ATPase activity, and the carboxy-terminal 
domain which contains the binding site for substrate peptides (Mayer, Bukau 2005, 
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Pierpaoli 2005, Wang, Chang & Wang 1993). These two parts are connected with a small 
linking region (Bertelsen et al. 2009). Hsp70 can have three different conformations: with 
ATP, with ADP or without the nucleotide. In the ATP-bound state, substrates can bind to 
and also dissociate from Hsp70 easily. When ATP is hydrolysed to ADP, the affinity of a 
substrate to Hsp70 becomes increased. The regulation of substrate binding is very 
important for the correct function of Hsp70. This is carried out by altering the ATPase 
activity with co-chaperones, such as Hsp40, and the substrates themselves (Mayer et al. 
2000, Pierpaoli 2005, Turturici, Sconzo & Geraci 2011). 
 
 
Figure 3. Domain structure of Hsp70. Amino-terminal domain, possessing ATPase activity and 
binding site for ATP/ADP, is connected with small linking region (LR) to carboxy-terminal 
domain (CTD), which have the ability bind to substrate peptides. 
 
The expression of Hsp70 is primarily regulated by a particular transcription factor, heat 
shock factor 1 (HSF1). HSF1 is also responsible for the induction of a number of other 
stress inducible genes (Abravaya et al. 1992, Anckar, Sistonen 2007, Pirkkala, Nykanen & 
Sistonen 2001). Under normal conditions, HSF1 exists as an inactivated monomer. The 
inactivation is achieved by Hsp90 and Hsp70 along with other chaperones. When the cell 
is exposed to stress, the complex breaks, HSF1 trimerizes, migrates to the nucleus and 
binds to the heat shock element (HSE) in the promoter site of hsp gene, leading to 
upregulation. When the level of Hsp70 is increased sufficiently, Hsp70 and HSF1 bind 
again and the expression is terminated (Ali et al. 1998, Morimoto 1998, Pirkkala, Nykanen 
& Sistonen 2001, Wu 1995, Zou et al. 1998). Although the expression of Hsp70 is mainly 
regulated transcriptionally, it has been demonstrated that mRNA stabilisation is also 
involved (Kaarniranta et al. 1998, Kaarniranta et al. 2000). 
 
A reduced ability to respond to stress at the cellular level is one of the major detrimental 
changes with aging (Haigis, Yankner 2010). It has been shown in many studies that the 
functional capacity of Hsp70 becomes impaired and also the expression is decreased in 
senescent cells and organisms (Heydari et al. 1993, Pierpaoli 2005, Shpund, Gershon 1997). 
Chaperone Hsp70 has been proven to be cytoprotective in stroke models (Giffard et al. 
2004, Hoehn et al. 2001, Rajdev et al. 2000). Several studies have also illustrated that the 
Hsp70 has cytoprotective effects in many models of neurodegenerative protein 
aggregation disorders (Brown 2007, Muchowski, Wacker 2005, Turturici, Sconzo & Geraci 
2011), such as Alzheimer’s (Magrane et al. 2004, Smith et al. 2005), Parkinson’s (Aridon et 
al. 2011, McLean et al. 2004) and Huntington's diseases (Hay et al. 2004, Tagawa et al. 
2007). Although AMD is recognised as a neurodegenerative, protein aggregation disease 
which is accompanied with senescence, surprisingly, only few studies have been 
conducted to elucidate the link between Hsp70 and AMD. There are few in vitro and in 
vivo studies indicating that Hsp70 may well possess a protective role in retinal cells as they 
try to respond to oxidative stress (Bailey et al. 2004, Park et al. 2007). 
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2.4.2 Hsp90 
Hsp90 is one of the most abundant proteins in mammalian cells; under non-stressful 
conditions it constitutes 1-2 % of all soluble proteins (Sreedhar, Soti & Csermely 2004, 
Taipale, Jarosz & Lindquist 2010). In the cytoplasm of mammalian cells, there is one 
inducible Hsp90 (Hsp90α) and one constitutively expressed (Hsp90β) protein. There are 
also Hsp90 proteins in endoplasmic reticulum and in mitochondria (Grp94 and tumor 
necrosis factor associated protein 1, Trap1, respectively) (Hahn 2009). 
 
Hsp90 is a dimer protein, comprising two Hsp90 monomers (Minami et al. 1991). These 
monomers have three domains (Fig. 4); an amino-terminal domain (NTD) and a carboxy-
terminal domain (CTD) connected by a middle domain. The NTD contains the ATP/ADP 
binding site and ATPase activity. In addition, many drugs, such as the Hsp90 inhibitor 
geldanamycin and its derivates, bind to the ATP-binding site (Pearl, Prodromou 2006). 
The CTD domain is involved in the dimerisation of the Hsp90 monomers (Minami et al. 
1994). The middle domain acts as a major binding site for client proteins of Hsp90 (Pearl, 
Prodromou 2006). 
 
 
Figure 4. Domain structure of Hsp90 monomer. Amino-terminal domain (NTD) has ATPase 
activity and the binding sites for ATP/ADP and as well for many drug molecules. Middle domain 
(MD) is an important for client protein binding and carboxy-terminal domain (CTD) for the 
dimerisation of two Hsp90 monomers. 
 
Although Hsp90 is expressed abundantly at the basal level, in most eukaryotic cells its 
expression doubles under stressful conditions (Taipale, Jarosz & Lindquist 2010). This 
induction is attributable to HSF1. Under non-stressful conditions, Hsp90 together with 
Hsp70, are attached to HSF1 thereby inactivating it. This complex becomes broken down 
during stress. There are also other molecules, such as NF-κB and interleukins, which 
regulate the expression of eukaryotic Hsp90 (Ammirante et al. 2008, Ripley et al. 1999, 
Stephanou et al. 1997). The co-chaperones of Hsp90 have a significant role in the 
regulation of Hsp90 function and they can act via many different mechanisms (Salminen 
et al. 2011, Zuehlke, Johnson 2010). The function of Hsp90 can also be altered by post-
transcriptional modifications, such as phosphorylation (Taipale, Jarosz & Lindquist 2010) 
and acetylation, by histone deacetylase 6 (HDAC6) (Kovacs et al. 2005a). 
 
According to Pratt et al. (2010), the Hsp90 molecular chaperone machinery is the most 
sophisticated chaperone machinery known in eukaryotes. Hsp90 regulates several 
different important cellular functions (Dezwaan, Freeman 2008, Taipale, Jarosz & 
Lindquist 2010). This chaperone has very wide range of client proteins including many 
kinases and transcription factors (Wandinger, Richter & Buchner 2008). Since these signal 
transducers have important roles in tumorigenesis, Hsp90 inhibitors, such as 
geldanamycin, have been widely studied in cancer research (Holzbeierlein, Windsperger 
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& Vielhauer 2010, Neckers 2007, Richardson et al. 2011a, Trepel et al. 2010). It has also 
been claimed that Hsp90 is involved in microtubule-linked protein trafficking 
(Kaarniranta et al. 2009, Kwon, Zhang & Matthias 2007). Similar to Hsp70, Hsp90 has also 
been linked to many neurodegenerative protein aggregation diseases (Solit, Chiosis 2008, 
Waza et al. 2006, Whitesell, Bagatell & Falsey 2003), such as Alzheimer’s (Dickey et al. 
2007, Luo et al. 2007, Luo, Rodina & Chiosis 2008) and Parkinson’s diseases (Falsone et al. 
2009). Likewise, very little is known about the role of Hsp70 and Hsp90 in AMD. One 
study detected elevated Hsp90 levels in the RPE cells of AMD patients (Decanini et al. 
2007). 
2.5 PROTEOLYSIS 
As discussed earlier, proteostasis is crucial for cellular well-being. Cells have to constantly 
evaluate the quality of their proteins in order to ensure their survival. While Hsps act 
primarily at the earlier, reconstructive level of this process, many proteolytic mechanisms 
come into play later, usually when the molecular chaperones have failed in their missions 
(Koga, Kaushik & Cuervo 2011). Many different physiological and pathological conditions 
(e.g. aging and oxidative stress) may lead to a state where the refolding capacity of 
chaperones is no longer sufficient. Without any compensatory mechanisms, this would 
result in accumulation of toxic misfolded proteins (Kroemer, Marino & Levine 2010, 
Wong, Cuervo 2010b). There are two main processing machineries in eukaryotic cells that 
take part in quality control by degrading proteins: 1) the ubiquitin-proteasome system 
(UPS) and 2) lysosomal/autophagosomal degradation system (Ciechanover 2005). These 
are separate pathways with their own unique characteristics, but they also share similar 
major steps. Both systems recognise and actively select the material for degradation, and 
when the proteins have been degraded, the end products, i.e. amino acids, are recycled 
(Wong, Cuervo 2010b). In both systems, molecular chaperones play important roles in the 
recognition and selection of the proteins to be degraded (Douglas, Summers & Cyr 2009). 
This selection process is essential; efficient non-selective degradation mechanisms would 
destroy also many crucial proteins (Goldberg 2003). Intracellular degradation, with the 
above-mentioned mechanisms, is usually the most effective way to remove the unwanted 
accumulated toxic proteins, although in some cases the proteins are secreted out of the 
cells (Wong, Cuervo 2010b). 
2.5.1 Ubiquitin-proteasome system (UPS) 
The UPS is responsible for the majority of regulated protein degradation in eukaryotes 
(Hochstrasser 1996, Ravid, Hochstrasser 2008) and it is the most important intracellular 
non-autophagosomal degradation system (Knecht et al. 2009). This degradation process 
consumes significant amount of ATP during its several steps (Bedford et al. 2010, Sorokin, 
Kim & Ovchinnikov 2009). Up to 1 % of cellular proteins are proteasomes (Coux, Tanaka 
& Goldberg 1996). Proteasomes can be found in almost all living organisms from Archaea to 
eukaryotes (Wojcik 2002). In eukaryotes, they are localised in both the nucleus and the 
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cytoplasm (Wojcik, DeMartino 2003). The proteasome, a 26S unit, is a large, over 2 MDa 
protease complex, which consists of two different components: catalytic core (20S) and 
regulatory particle (19S) on one or both ends of the 20S (Wojcik 2002). By strictly 
controlling the UPS, cells can regulate many central cellular functions, such as the cell 
cycle, apoptosis, metabolism, DNA repair, transcription, signal transduction and, of course 
protein quality (Wong, Cuervo 2010b). 
 
The proteins that have been selected for degradation in proteasomes are first tagged 
covalently with ubiquitin - a small, 8.5 kDa abundant protein found in all eukaryotic cells 
(Ciechanover 2005). This highly stable molecule is bound to its substrates via specific 
enzymes (Hershko, Ciechanover 1998) which also have a role in the selection of substrates 
for degradation (Ravid, Hochstrasser 2008). In addition, some chaperones (e.g. Hsp70 and 
Hsp90) and Hsp-interacting molecules (carboxyl terminus of Hsc70-interacting protein, 
CHIP) recognise non-native proteins for degradation (Murata et al. 2001, Ravid, 
Hochstrasser 2008). It has been said that ubiquitin conjugation is a kind of a “kiss of 
death” for proteins (Grillari, Katinger & Voglauer 2006). This is not completely true 
because proteins may be ubiquitinated for several other reasons; proteins can be tagged 
for transport outside of the cell (instead of targeted to proteasomes), or as a signal to 
promote DNA repair (Pickart 2002) or alter other aspects of cell signalling (Chen 2005). 
The destiny of ubiquitinated proteins depends on the way in which ubiquitin is 
conjugated to the substrate. Proteins earmarked for proteasomal degradation are usually 
tagged with at least four ubiquitin molecules (Clague, Urbe 2010). The different ubiquitin 
stamps on the proteins to be dismantled influence the degradation kinetics of the 
proteasome complex (Xu et al. 2009). Ubiquitinated proteins bind to ubiquitin receptors in 
proteasomes. The ubiquitin molecules must be removed before degradation; this is 
achieved by deubiquitinating enzymes. In this way, the ubiquitin can be recycled and the 
need for ubiquitin synthesis is reduced (Reyes-Turcu, Ventii & Wilkinson 2009). In 
addition, this provides one more regulatory point before ultimate protein degradation. 
Proteasomes can also degrade proteins without ubiquitination but the purpose and scope 
of this mechanism are still unclear (Benaroudj et al. 2001, Hoyt, Coffino 2004, Shringarpure 
et al. 2003). 
2.5.2 Autophagosomal/lysosomal degradation 
There are three different autophagic mechanisms; 1) macroautophagy, 2) microautophagy 
and 3) chaperone-mediated autophagy (CMA). Autophagy means “self-eating”. In 
autophagy (or more precisely in macro- and microautophagy) a part of the cytoplasm is 
engulfed with the lipid membrane and degraded by lysosomes (Glick, Barth & Macleod 
2010). In general, all lysosomal degradation of intracellular components is referred to as 
autophagy. In addition, lysosomes can degrade material from outside the cytoplasm via 
phagocytosis and endocytosis (Schulze, Kolter & Sandhoff 2009). Within the lysosomes, 
one can find a wide array of hydrolases, such as proteases, lipases and nucleotidases 
(Schroder et al. 2010). There are ATP-dependent proton pumps in the lysosomal 
membranes which reduce the lysosomal pH (Arai et al. 1993, Ezaki, Himeno & Kato 1992). 
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This acidic environment improves the enzymatic activity of degrading enzymes, and it has 
been postulated that it also assists in the unfolding of the substrate proteins and thus helps 
the binding of hydrolases (Schroder et al. 2010). Autophagy is the only degradation 
mechanism in cells that can degrade entire cellular organelles and other large structures, 
such as protein aggregates (Rabinowitz, White 2010). Autophagosomal degradation has 
many important functions: it takes part in protein quality control, cellular defence, 
apoptosis, and it can provide energy and supply of amino acids through catabolism 
(Mizushima et al. 2008). This degradative pathway is activated in response to many 
stressors, such as starvation, oxidative stress, DNA damage and unfolded protein 
response (Kroemer, Marino & Levine 2010), but also a basal activity of macroautophagy 
(Hara et al. 2006, Komatsu et al. 2005, Komatsu et al. 2006) and CMA have been detected 
(Massey, Zhang & Cuervo 2006). 
 
Macroautophagy is the major form of autophagy and often it is referred to simply as 
autophagy (Funderburk, Marcellino & Yue 2010). In macroautophagic degradation, a 
portion of the cytoplasm, with or without organelles, is sequestered by a de novo formed 
double-membrane vesicle called the autophagosome. This vesicle then matures and 
integrates with the lysosomes (or endosomes) and its contents are degraded (Eskelinen 
2005, Jager et al. 2004, Yang, Klionsky 2009). Macroautophagy is regulated by many 
autophagy-related genes (ATG) (Mehrpour et al. 2010). Macroautophagic cargo 
recognition is usually non-selective; however, it can also be selective for a particular cargo, 
such as aggregated proteins and dysfunctional organelles (Bejarano, Cuervo 2010). In 
microautophagy, it is the lysosome itself that directly invaginates the cytoplasmic portion 
without the formation of any additional vesicles. Microautophagy has been well-
characterised in yeast (Roberts et al. 2003, Sakai et al. 1998, Sattler, Mayer 2000) but is still 
poorly understood in mammalian cells (Santambrogio, Cuervo 2011). In contrast to the 
previously described autophagic pathways, CMA degrades only soluble cytosolic 
proteins. These proteins are selectively recognised, with the help of chaperones (mainly 
Hsc70) (Chiang et al. 1989) and co-chaperones (such as Hsp90 and Hsp40) (Agarraberes, 
Dice 2001), and transferred to the lysosomal surface, where lysosome-associated 
membrane protein type 2A (LAMP-2A) acts as a receptor (Cuervo, Dice 1996, Cuervo, Dice 
2000b), and then transported further inside the lysosomal lumen for degradation 
(Bejarano, Cuervo 2010). 
 
The autophagic systems are not completely separate from each other. The two main forms, 
macroautophagy and CMA, are upregulated in starvation (Cuervo et al. 1995). However, 
macroautophagy acts at the first line and reaches its maximal activity within a couple of 
hours. If increased non-selective macroautophagy cannot eliminate the nutritional 
deprivation by dismantling and recycling intracellular molecules, then CMA will be 
induced and the macroautophagy will gradually decline to its basal level (Bejarano, 
Cuervo 2010). In addition, inhibition of one autophagic pathway has been demonstrated to 
induce the other (Kaushik et al. 2008, Massey et al. 2006). However, compensation 
between macroautophagy and CMA cannot be complete; for example, while CMA can 
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degrade only proteins, macroautophagy can destroy whole cellular organelles. Little is 
known about the fundamentals of microautophagy and even less is understood about the 
cross-talk between microautophagy and other autophagic pathways. 
 
There is also a clear linkage between the autophagic pathways and the ubiquitin-
proteasome system (Ding et al. 2007, Korolchuk, Menzies & Rubinsztein 2010). Acute 
blockage of proteasomal degradation has resulted in upregulation of macroautophagy in 
different cells (Iwata et al. 2005a). While chronic low-level proteasome inhibition was able 
to induce macroautophagy, it also altered the lysosomal activity and decreased the 
reserves of lysosomal degradation (Ding et al. 2003). In addition, it has been speculated 
that ubiquitin might be one of the linkage factors between autophagy and UPS; it has been 
proposed that ubiquitin has also a role in selective autophagy (Kirkin et al. 2009). 
2.6 IMPAIRED PROTEOLYSIS AND PROTEIN AGGREGATION 
Impaired proteolysis is an inevitable by-product of aging. The activities of UPS, 
macroautophagy and CMA have been shown to decrease during aging (Conconi et al. 
1996, Cuervo, Dice 2000a, Del Roso et al. 2003, Donati et al. 2001, Kiang, Tsokos 1998, 
Ponnappan, Zhong & Trebilcock 1999, Shibatani, Ward 1996), this also applies to RPE cells 
(Li et al. 2008). Impaired proteolysis has also been identified in many human pathologies 
(Bingol, Sheng 2011, Huang, Figueiredo-Pereira 2010, Wong, Cuervo 2010a). Since 
proteolysis is involved in many important functions under normal physiological states 
and especially during stressful conditions, proteolytic failure can be highly detrimental to 
cells (Hara et al. 2006, Komatsu et al. 2006, Nedelsky, Todd & Taylor 2008), one of the 
direct outcomes of it being aggregation of proteins. Typically accumulated misfolded 
proteins have their hydrophobic residues exposed on the surface. These hydrophobic 
components have a tendency to bind together and aggregate (Tyedmers, Mogk & Bukau 
2010). Eventually, the aggregated proteins gather with other proteins, such as molecular 
chaperones, ubiquitin and proteasomes, and may end up forming large aggregates (Kopito 
2000), which in turn bind to HDAC6 and are trafficked via dynein-motor and microtubule 
network, near to the nucleus to the MTOC (microtubule-organising center) where they 
form even larger aggregates, so-called aggresomes (Kawaguchi et al. 2003, Kopito 2003). 
While protein aggregates have been proven to be toxic, it is still not perfectly clear whether 
the formation of aggregates is a toxic end-result, an attempt by the cell to protect itself 
from even more toxic stimuli, or perhaps, something in between (Bretteville, Planel 2008, 
Congdon, Duff 2008, Gotz et al. 2008, Tyedmers, Mogk & Bukau 2010, Wolfe, Cyr 2011). 
Nonetheless, the aggregation of different kinds of proteins is one of the key elements in 
many age-related, degenerative diseases (Aguzzi, O'Connor 2010). 
 
Several exo- and endogenic factors, such as senescence, oxidative stress and 
disadvantageous genotype eventually lead to inadequate protein degradation and thus to 
protein aggregation. In addition, in many diseases these aggregated toxic proteins usually 
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tend to inhibit still further the poorly functioning UPS and/or autophagic pathways 
(Bennett et al. 2005, Betarbet, Sherer & Greenamyre 2005, Cuervo et al. 2004, Keck et al. 
2003, Landles, Bates 2004, Wang et al. 2009). The disturbances in UPS have been strongly 
linked to the pathology encountered in Alzheimer’s (Gregori et al. 1997, Keller, Hanni & 
Markesbery 2000, Oddo 2008) and Parkinson’s diseases (Cuervo, Wong & Martinez-
Vicente 2010), although the direct neurodegenerative link has been recently questioned in 
the Parkinson’s disease (Matsuda, Tanaka 2010). Dysfunctional autophagy has also been 
characterised in Alzheimer’s (Boland et al. 2008, Nixon et al. 2005, Nixon 2007, Yu et al. 
2005) and Parkinson’s diseases (Michiorri et al. 2010, Narendra et al. 2008). A healthy 
lifestyle may also be connected to proteostasis; severe downregulation of autophagy has 
been observed in a murine obesity model (Yang et al. 2010), and the β-cells of type 2 
diabetes patients accumulate ubiquitin-protein conjugates in the same way as occurs in the 
damaged neurons in patients with Alzheimer's and Parkinson's diseases (Costes et al. 
2011). 
2.7 PROTEIN AGGREGATION IN THE RPE CELLS AND AMD 
As discussed earlier, many AMD-linked stressful conditions, such as hypoxia, oxidative 
stress, unfolded protein response and inflammation, are states that normally induce the 
Hsp response and trigger activity in cellular proteolytic pathways. Unfortunately, these 
activities decline in senescent cells when they are needed the most. At the same time the 
stressful conditions may become even more severe. In the retina and RPE cells, this results 
in the accumulation of intracellular (lipofuscin) and extracellular (drusen) protein 
aggregates. Drusen have been shown to be ubiquitin positive (Anderson et al. 2004, 
Mullins et al. 2000). In addition, markers for autophagy and exosomes have also been 
found in drusen (Wang et al. 2009). These observations implicate a connection between 
intracellular protein aggregation and extracellular drusen formation. Retinal protein 
aggregation is one of the major changes encountered in AMD (Kaarniranta et al. 2009, 
Kaarniranta et al. 2010). Protein aggregation and degeneration in senescent RPE cells is a 
complex and multifactorial process. The RPE cells must endure enormous chronic 
oxidative stress throughout their, perhaps 80 year or longer, lifespan, while the 
compensatory mechanisms against various exo- and endogenic stresses fail inevitably little 
by little with time. Although many details are known about these processes, there are still 
several aspects that need to be elucidated in the future before there is complete 
understanding of protein aggregation in RPE cells and its relationship to AMD. 
 
One of the most important tasks of RPE cells is the clearance of lipid-rich outer segments 
of photoreceptors. After phagocytosis, this material is directed to lysosomes for 
degradation (Kevany, Palczewski 2010, Nguyen-Legros, Hicks 2000). In senescent RPE 
cells, the degradative mechanisms have become dysfunctional leading to the accumulation 
of a phototoxic (Brunk et al. 1995, Wihlmark et al. 1997) lysosomal lipid-protein material 
called lipofuscin (Geng, Wihlmark & Algvere 1999, Kennedy, Rakoczy & Constable 1995, 
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Murdaugh et al. 2011, Warburton et al. 2005, Wihlmark et al. 1996). Lipofuscin has also 
been considered as an “aging pigment” and widely recognised as a hallmark of aging in 
many different cells. Since lipofuscin is undegradable and cannot be removed via 
exocytosis, the only way to reduce its level is to dilute it through cell division. This is a 
major problem for non-dividing post-mitotic cells, such as RPE cells (Brunk, Terman 2002, 
Terman, Brunk 1998, Terman, Brunk 2004). 
 
Lipofuscin has many pernicious effects on cellular well-being. It has been demonstrated to 
reduce the function of lysosomes (Grune et al. 2005, Holz et al. 1999), proteasomes (Grune 
et al. 2005, Hohn et al. 2011, Sitte et al. 2000), and also to promote apoptosis (Powell et al. 
2005). Conversely, an inhibition of UPS or autophagy leads to lipofuscin formation 
(Stroikin et al. 2004, Terman, Sandberg 2002). In addition, the phagocytic activity of RPE 
cells will be decreased as a consequence of lipofuscin accumulation (Sundelin et al. 1998). 
Fluorophore A2E (N-retinylidene-N-retinyl-ethanolamine) is a major molecular 
component of lipofuscin (Sparrow et al. 2003). This molecule induces the harmful effects of 
light (Kim et al. 2006, Schutt et al. 2000, Sparrow et al. 2008) and has also been 
demonstrated to inhibit the acidification of lysosomes, and therefore their function 
(Bergmann et al. 2004). A2E may also have a role in the exudative form of AMD associated 
with neovascularisation; in mice, it has induced the expression of vascular endothelial 
growth factor (VEGF) in RPE and choroid (Iriyama et al. 2009). 
 
Lipid peroxidation is a common event in aging cells (Negre-Salvayre et al. 2010). This 
leads to the formation of lipid-peroxidation products, such as 4-hydroxy-2-nonenal (HNE) 
and malondialdehyde, which are closely linked to age-related degenerative diseases, as 
well as many other illnesses (Butterfield, Bader Lange & Sultana 2010, Dmitriev, Titov 
2010, Mattson 2009). In the retina, oxidative stress is always present and therefore there is 
continued formation of large amounts of lipid-peroxidation products. These products 
trigger detrimental protein modifications in the POS. Phagocytosis of modified POS in 
turn leads to the induction of lipofuscin formation and a reduction in the autophagic 
activity in RPE cells (Kaemmerer et al. 2007, Krohne et al. 2010b, Krohne, Holz & Kopitz 
2010). The lipid-peroxidation products are capable of evoking lipofuscinogenesis and 
dysfunctional lysosomal degradation in RPE cells also by themselves (Krohne et al. 2010a). 
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3 Aims of the Study 
One of the first clinical alterations of AMD is the accumulation of protein aggregates 
between RPE cells and Bruch’s membrane. Intracellular accumulation of lysosomal 
lipofuscin is also closely linked to AMD. Many studies have provided a body of evidence 
suggesting that progressive degeneration of RPE cells plays an essential role in the 
pathogenesis of AMD. The main purpose of this study was to clarify the mechanisms 
underpinning protein aggregation and its possible reversal in RPE cells. It is believed that 
it may be possible to influence positively the progression, or even the onset of the AMD by 
removing the protein aggregates or inhibiting their formation. 
 
Specific questions for the study were: 
 
1. How does the lipid-peroxidation product 4-hydroxy-2-nonenal (HNE) affect the 
function of RPE cells? 
2. Is it possible to achieve cytoprotective effects of upregulated Hsp70 by using an 
Hsp90 inhibitor in RPE cells? Do the effects of two Hsp90 inhibitors differ? 
3. What kind of protein aggregation does the proteasome inhibitor MG-132 generate, 
and what is the role of Hsp70 in this process? 
4. Do the RPE cells have the ability to remove proteasome inhibitor-induced 
aggregates, and if so, by what mechanisms? 
5. Is it possible to affect the proteasome inhibitor-induced aggregation by modulating 
Hsp levels and the microtubular network? 
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4 Material and Methods 
4.1 CELL CULTURE AND TREATMENTS 
The cells used in this research were ARPE-19 cells (human adult retinal pigment epithelial 
cell line) obtained from American Type Culture Collection (ATCC). The cells were grown 
in normal cell culture incubator containing a humidified atmosphere of 10 % CO2 and +37 
°C. Dulbecco's MEM/Nut MIX F-12 (1:1) (cat. no. 21331020, Life Technologies, Invitrogen, 
GIBCO®, Paisley, UK) containing 10 % fetal bovine serum (cat. no. CH30160.03, Thermo 
Scientific, Hyclone, Logan, UT, USA), 100units/ml penicillin + 100μg/ml streptomycin (cat. 
no. DE17-602E, Lonza, Basel, Switzerland) and 2mM L-glutamine (cat. no. BE17-605E, 
Lonza) was used as a medium. Various cell culture dishes and plates were used (Greiner 
Bio-One, Frickenhausen, Germany; Sigma-Aldrich, Steinheim, Germany; Thermo-
Scientific, Waltham, MA, USA). Cells were subcultured two times a week. In addition to 
subculturing, the medium was changed once a week. The passage of the cells was between 
5 and 20 in all test series. The exposures (described below) started when the cells had 
achieved full confluency, except the transfections were done with 50-70 % confluent cells.  
 
Proteasomes were inhibited with proteasome inhibitor, MG-132 (cat. no. 474790, Merck, 
Calbiochem®, Darmstadt, Germany) using concentrations from 5μM to 10μM. The 
function of lysosomes was disrupted with NH4Cl (10mM) and bafilomycin A1 (cat. no. 
B1793, Sigma-Aldrich) at a concentration of 100nM. The formation of autophagosomes 
was blocked by 10mM 3-methyladenine (cat. no. M9281, Sigma-Aldrich). Molecular 
chaperone Hsp90 was inhibited with 0.1-5μM geldanamycin (cat. no. 345805, Merck, 
Calbiochem®) or 0.1-5μM radicicol (cat. no. BML-EI285, Enzo Life Sciences, Farmingdale, 
NY, USA). Taxol (cat. no. 580555, Merck, Calbiochem®), at concentration of 1μM, and 
5μM nocodazole (cat. no. 487928, Merck, Calbiochem®) were used to disrupt the function 
of microtubules. Trichostatin A (cat. no. T8552, Sigma-Aldrich), at concentration of 1μM, 
was used to acetylate microtubules. 4-hydroxy-2-nonenal (HNE, cat. no. 393204, Merck, 
Calbiochem®) was used to mimic lipid peroxidation-induced oxidative stress and okadaic 
acid (cat. no. 459620, Merck, Calbiochem®) to inflict caspase 3-dependent cell death. 
4.2 WESTERN BLOTTING 
Exposed cells were scraped from cell culture plates into lysis buffer. Either commercial M-
Per (Thermo-Scientific) or self-made buffer (25 % glycerol, 0.42M NaCl, 1.5mM MgCl2, 
0.2mM EDTA, 20mM HEPES) were used. After centrifugation (13 700g, 10min, + 4 °C) the 
soluble proteins were collected. Protein concentrations were measured using the Bradford-
method (Bradford 1976, Marshall, Williams 1992, Zor, Selinger 1996) based on the change 
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of Coomassie brilliant blue G-250 colour when the reagent binds to proteins. Briefly, 1-2μl 
of samples were pipetted into 96-well plates (Sigma-Aldrich) and 200μl of Bradford 
reagent (120μM Coomassie brilliant blue G-250, 5 % EtOH, 8.5 % phosphoric acid) was 
added and samples were measured in a spectrophotometer at 595nm. Known BSA (bovine 
serum albumin) concentrations were used to construct a standard curve. 
 
From ten to twenty micrograms of whole cell protein extracts were pipetted to the wells of 
a 10 % or 15 % SDS-PAGE gel. After electrophoresis, the proteins were transferred to 
nitrocellulose membrane (GE Healthcare, Chalfont St Giles, United Kingdom) either via 
wet-blotting or in a semi-dry apparatus (Bio-Rad, Hercules, CA, USA). The membranes 
were blocked to prevent non-specific antibody binding. Blocking times and solutions are 
shown in table 1. Next, the membranes were rinsed quickly with 1 x PBS and incubated 
with primary antibodies (table 2). After the washes (table 1), the membranes were 
incubated with horseradish peroxidase-conjugated secondary antibodies (table 3) and 
washed as before (table 1). The proteins were detected from membranes with an enhanced 
chemiluminescence method (Millipore, Billerica, MA, USA; Thermo-Scientific). Some of 
the Western blots were quantified with Quantity One software 4.5.0. (Bio-Rad). 
4.3 IMMUNOFLUORESCENCE 
To identify the localisation of particular proteins (Hsp70, ubiquitin, LAMP-1, LAMP-2) 
immunofluorescence analyses were conducted. The cells, which had been grown and 
exposed on untreated thin glass slides at the bottom of 12-well plate wells, were fixed with 
fresh formaldehyde made from paraformaldehyde (1 % in 1 x PBS, 10min, RT). In order to 
permit the entry of antibodies into the cells, the samples were first permeabilised (0.2 % 
Triton X-100 in 1 x PBS, 10min, 4 °C). The samples were blocked with non-specific proteins 
(table 1) to minimise the binding of antibodies to sites other than their epitopes. 
Subsequently, the samples were incubated first with primary antibody (table 2) and then 
with secondary antibody (table 3). The samples were washed after both treatments (table 
1) to remove any surplus antibodies. The nuclei of a group of samples were stained with 
Hoechst 33258 dye (0.5μM/ml, 10min, RT, followed by 4 x 1min washes with 1 x PBS) to 
ease the interpretation of the results. Glass slides containing the stained cells were taken 
out of the wells and mounted onto objective glasses with mounting medium. Micrographs 
were taken with Nikon Eclipse TE300 (Nikon, Tokyo, Japan) microscope equipped with a 
Nikon E995 digital camera or with a confocal microscope (Nikon Eclipse TE300). 
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Table 1. Blocking and washing circumstances of Western blotting and immunocytochemistry. 
 
 
Primary 
antibody 
 
Blocking solution 
 
Incubation 
 
Wash solution 
Washes after 
antibody 
treatments 
Hsp27, mouse 
mAb 
1 3 % fat-free dry milk in 
0.3 % Tween 20/1 x PBS 
1 1.5h at RT 1 0.3 % Tween 20/1 x 
PBS 
1 3 x 5min 
Hsc70, mouse 
mAb 
1 3 % fat-free dry milk in 
0.3 % Tween 20/1 x PBS 
1 1.5h at RT 1 0.3 % Tween 20/1 x 
PBS 
1 3 x 5min 
Hsp70, mouse 
mAb 
1 3 % fat-free dry milk in 
0.3 % Tween 20/1 x PBS 
1 1.5h at RT 1 0.3 % Tween 20/1 x 
PBS 
1 3 x 10min or 
1 3 x 5min 
Hsp70, rat 
mAb 
2 3 % fat-free dry milk in 
0.05 % Tween/1 x PBS 
2 30 min at RT 2 1 x PBS 2 3 x 5min 
Hsp90, rat 
mAb 
1 3 % fat-free dry milk in 
0.3 % Tween 20/1 x PBS  
1 1.5h at RT 1 0.3 % Tween 20/1 x 
PBS 
1 3 x 10min 
Ubiquitin, 
rabbit pAb 
1 3 % fat-free dry milk in 
0.3 % Tween 20/1 x PBS  
2 3 % fat-free dry milk in 
0.05 % Tween/1 x PBS 
1 1.5h at RT
2 30 min at RT 
1 0.3 % Tween 20/1 x 
PBS 
2 1 x PBS 
1 3 x 10min 
2 3 x 5min 
SOD, mouse 
mAb 
1 5 % fat-free dry milk in 
0.05 % Tween/1 x PBS 
1 1.5h at RT 1 0.05 % Tween/1 x 
PBS 
1 3 x 5min 
HNE, rabbit 
pAb 
1 5 % fat free dry milk in 
0.05 % Tween/1 x PBS 
1 1.5h at RT 1 0.05 % Tween/1 x 
PBS 
1 3 x 5min 
β-actin, 
mouse mAb 
1 5 % fat-free dry milk in 
0.05 % Tween/1 x PBS 
1 1.5h at RT 1 0.05 % Tween/1 x 
PBS 
1 3 x 5min 
LAMP-1, 
mouse mAb 
2 3 % fat-free dry milk in 
0.05 % Tween/1 x PBS 
2 30 min at RT 2 1 x PBS 2 3 x 5min 
LAMP-2, 
mouse mAb 
2 3 % fat-free dry milk in 
0.05 % Tween/1 x PBS 
2 30 min at RT 2 1 x PBS 2 3 x 5min 
Tubulin, 
mouse mAb 
1 3 % fat-free dry milk in 
0.3 % Tween 20/1 x PBS 
1 1h at RT 1 0.05 % Tween/1 x 
PBS 
1 3 x 5min
Acetylated 
tubulin, 
mouse mAb 
1 3 % fat-free dry milk in 
0.3 % Tween 20/1 x PBS 
1 1h at RT 1 0.05 % Tween/1 x 
PBS 
1 3 x 5min
LC3, rabbit 
pAb 
1 3 % fat-free dry milk in 
0.3 % Tween 20/1 x PBS 
1 1h at RT 1 0.3 % Tween 20/1 x 
PBS 
1 3 x 5min
1 Western blotting, 2 Immunofluorescence 
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Table 2. Primary antibodies used in Western blotting and immunocytochemistry. 
 
Primary 
antibody 
 
Dilution 
 
Diluted in 
 
Incubation 
 
Obtained from 
Hsp27, mouse 
mAb, cat. SPA-
800D 
1 1:2 500 1 0.5 % BSA in 0.3 % 
Tween 20/1 x PBS 
1 overnight at 4 °C Enzo Life Sciences, 
StressGen® 
Hsc70, mouse 
mAb, cat. SPA-815 
1 1:5 000 1 0.5 % BSA in 0.3 % 
Tween 20/1 x PBS 
1 2h at RT Enzo Life Sciences, 
StressGen® 
Hsp70, mouse 
mAb, cat. SPA-810 
1 1:5 000 1 0.5 % BSA in 0.3 % 
Tween 20/1 x PBS 
1 overnight at 4 °C 
or 1 2h at RT 
Enzo Life Sciences, 
StressGen® 
Hsp70, rat mAb, 
cat. 4873 
2 1:50 2 0.05 % Tween 20/1 x 
PBS 
2 1h at RT Cell Signaling 
Technology, Danvers, 
MA, USA 
Hsp90, rat mAb, 
cat. SPA-835 
1 1:5 000 1 0.5 % BSA in 0.3 % 
Tween 20/1 x PBS 
1 overnight at 4 °C Enzo Life Sciences, 
StressGen® 
Ubiquitin, rabbit 
pAb, cat. Z0458 
1 1:500 
2 1:80 
1 0.5 % BSA in 0.3 % 
Tween 20/1 x PBS 
2 0.05 % Tween 20/1 x 
PBS 
1 overnight at 4 °C 
2 1h at RT 
Dako, Glostrup, 
Denmark 
SOD, mouse mAb, 
cat. SOD-110 
1 1:2 500 1 0.5 % BSA in 0.05 % 
Tween 20/1 x PBS 
1 overnight at 4 °C Enzo Life Sciences, 
StressGen® 
HNE, rabbit pAb, 
cat. ALX-210-767 
1 1:2 000 1 0.5 % BSA in 0.05 % 
Tween 20/1 x PBS 
1 overnight at 4 °C Enzo Life Sciences, 
Alexis® 
β-actin, mouse 
mAb, cat. A5441 
1 1:1 000 1 0.5 % BSA in 0.05 % 
Tween 20/1 x PBS 
1 overnight at 4 °C Sigma-Aldrich 
LAMP-1, mouse 
mAb, cat. H4A3 
2 1:35 1 0.05 % Tween 20/1 x 
PBS 
2 1h at RT Developmental Studies 
Hybridoma Bank, Iowa 
City, IA, USA 
LAMP-2, mouse 
mAb, cat. H4B4 
2 1:20 1 0.05 % Tween 20/1 x 
PBS 
2 1h at RT Developmental Studies 
Hybridoma Bank 
Tubulin, mouse 
mAb, cat. T6793 
1 1:4 000 1 1 % fat-free dry milk 
in 0.05 % Tween 20/1 x 
PBS 
1 30min at RT Sigma-Aldrich 
Acetylated tubulin, 
mouse mAb, cat. 
T5168 
1 1:8 000 1 1 % fat-free dry milk 
in 0.05 % Tween 20/1 x 
PBS 
1 0.5h at RT Sigma-Aldrich 
LC3, rabbit pAb, 
cat. AP1802a 
1 1:250 1 0.5 % BSA in 0.05 % 
Tween 20/1 x PBS 
1 1h at RT Abgent, San Diego, 
CA, USA 
1 Western blotting, 2 Immunofluorescence 
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Table 3. Secondary antibodies used in Western blotting and immunocytochemistry. 
 
Primary 
antibody 
Secondary 
antibody 
 
Dilution 
 
Diluted in 
 
Incubation 
 
Obtained from 
Hsp27, mouse 
mAb 
1 horseradish 
peroxidase-
conjugated anti-
mouse, cat. NA931V 
1 1:10 000 1 3 % fat-free 
dry milk in 0.3 
% Tween 20/1 
x PBS 
1 2h at RT GE Healthcare 
Hsc70, rat 
mAb 
1 horseradish 
peroxidase-
conjugated anti-rat, 
cat. NA935V 
1 1:20 000 1 3 % fat-free 
dry milk in 0.3 
% Tween 20/1 
x PBS 
1 2h at RT GE Healthcare 
Hsp70, mouse 
mAb 
1 horseradish 
peroxidase-
conjugated anti-
mouse, cat. NA931V 
1 1:20 000 
1 1:50 000 
1 3 % fat-free 
dry milk in 0.3 
% Tween 20/1 
x PBS 
1 2h at RT GE Healthcare 
Hsp70, rat 
mAb 
2 anti-rat, Alexa 
Fluor® 488, cat. 
4416 
2 1:1 000 2 0.05 % Tween 
20/1 x PBS 
2 1h at RT Cell Signalling 
Technology, 
Danvers, MA, USA 
Hsp90, rat 
mAb 
1 horseradish 
peroxidase-
conjugated anti-rat, 
cat. NA935V 
1 1:20 000 1 3 % fat-free 
dry milk in 0.3 
% Tween 20/1 
x PBS 
1 2h at RT GE Healthcare 
Ubiquitin, 
rabbit pAb 
1 horseradish 
peroxidase-
conjugated anti-
rabbit, cat. NA934V  
2 anti-rabbit, Alexa 
Fluor® 488, cat. 
4412 
1 1:20 000 
2 1:1 000 
 
1 3 % fat-free 
dry milk in 0.3 
% Tween 20/1 
x PBS 
2 0.05 % Tween 
20/1 x PBS 
1 2h at RT 
2 1h at RT 
1 GE Healthcare 
2 Cell Signalling 
Technology 
SOD, mouse 
mAb 
1 horseradish 
peroxidase-
conjugated anti-
mouse, cat. NA931V 
1 1:10 000 1 5 % fat-free 
dry milk in 0.05 
% Tween 20/1 
x PBS 
1 2h at RT GE Healthcare 
HNE, rabbit 
pAb 
1 horseradish 
peroxidase-
conjugated anti-
rabbit, cat. NA934V 
1 1:10 000 1 5 % fat-free 
dry milk in 0.05 
% Tween 20/1 
x PBS 
1 2h at RT GE Healthcare 
β-actin, 
mouse mAb 
1 horseradish 
peroxidase-
conjugated anti-
mouse, cat. NA931V 
1 1:10 000 1 5 % fat-free 
dry milk in 0.05 
% Tween 20/1 
x PBS 
1 2h at RT GE Healthcare 
LAMP-1, 
mouse mAb 
2 anti-mouse, Alexa 
Fluor® 488, cat. 
4408 
2 1:1 000 2 0.05 % Tween 
20/1 x PBS 
2 1h at RT Cell Signalling 
Technology 
LAMP-2, 
mouse mAb 
2 anti-mouse, Alexa 
Fluor® 488, cat. 
4408 
2 1:1 000 2 0.05 % Tween 
20/1 x PBS 
2 1h at RT Cell Signalling 
Technology 
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Tubulin, 
mouse mAb 
1 horseradish 
peroxidase-
conjugated anti-
mouse, cat. NA931V 
1 1:10 000 1 1 % fat-free 
dry milk in 0.05 
% Tween 20/1 
x PBS 
1 30min at  
RT 
GE Healthcare 
Acetylated 
tubulin, 
mouse mAb 
1 horseradish 
peroxidase-
conjugated anti-
mouse, cat. NA931V 
1 1:6 000 1 1 % fat-free 
dry milk in 0.05 
% Tween 20/1 
x PBS 
1 1h at RT GE Healthcare 
LC3, rabbit 
pAb 
1 horseradish 
peroxidase-
conjugated anti-
rabbit, cat. NA934V 
1 1:5 000 1 3 % fat-free 
dry milk in 0.3 
% Tween 20/1 
x PBS 
1 1h at RT GE Healthcare 
1 Western blotting, 2 Immunofluorescence 
4.4 CELLULAR VIABILITY 
4.4.1 MTT-assay 
Mitochondria possess enzymes that will reduce the yellow MTT tetrazole salt (3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium-bromide) to purple formazan. The amount 
of purple formazan can be measured spectrophotometrically (570nm). The formed purple 
formazan colour is directly proportional to the viability of the cells. 
 
The MTT-assay (Hansen, Nielsen & Berg 1989) was conducted as follows. After the 
exposures of the cells in 12-well plates, the amount of medium in each well was 
standardised to 500μl and the fresh MTT salt solution (10mg/ml in 1 x PBS) was added 
(25μl/well). The incubation time was 1.5h in a normal cell culture incubator. MTT-lysis 
buffer (20 % SDS, 50 % N,N-dimethylformamide, 2 % acetic acid, 25mM HCl) were added 
(525μl) to lyse the cells and to dissolve the purple formazan into solution. The plates were 
packed air tightly with parafilm to prevent evaporation and incubated overnight in a cell 
culture incubator. The cell lysate solutions were collected, centrifuged (5min, 13 700g) and 
measured in a spectrophotometer at 570nm. The statistically significant differences were 
determined by Mann-Whitney U-test (n=6). 
4.4.2 Caspase 3 
Caspase 3 is an enzyme which is activated in early apoptosis. Synthetic Ac-DEVD-AMC is 
a tetrapeptide fluorogenic substrate for caspase 3. When Ac-DEVD-AMC binds to caspase 
3, fluorescent AMC is released from the substrate. The fluorescence can be measured 
spectrofluorometrically (excitation 380nm and emission 440nm). The amount of 
fluorescence indicates the relative level of apoptosis. The caspase 3-assay (Ac-DEVD-AMC 
Caspase-3 Fluorogenic Substrate, BD Pharmingen™, cat. no. 556449, BD Biosciences, San 
Diego, CA, USA) was conducted according to the manufacturer’s instructions. The final 
concentration of the substrate used was 20μM (n=4). 
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4.4.3 ApopTag 
Many morphological changes occur when cells undergo apoptosis, one of which is DNA 
fragmentation. The ApopTag® Plus Peroxidase In Situ Apoptosis Detection Kit (Millipore) 
can be used to label the 3’-OH termini of DNA fragments (TUNEL assay). The assay was 
performed following the manufacturer’s instructions. The apoptotic cells were visualised 
in a phase contrast microscope. 
4.4.4 Fluorescent staining of living and dead cells 
Fluorescein diacetate (Sigma-Aldrich) penetrates into living cells where it is hydrolysed 
producing a green fluorescence. The impermeable red fluorescent dye, propidium iodide 
(Sigma) can penetrate through degraded cell membranes of dead cells and bind to DNA. 
The viability analysis was conducted as described earlier (Chen et al. 2003). The living and 
the dead cells were counted within a fixed area in a fluorescence microscope (Olympus 
IX71, light source Olympus Cell MT-10, Olympus, Tokyo, Japan). Statistically significant 
differences were estimated with the Mann-Whitney U-test (n=9). 
4.5 RNA INTERFERENCE 
The siRNA (small interfering RNA) technique is based on the RNA interference 
phenomenon where small, initially double-stranded RNA molecules can become attached 
to a complementary sequence of messenger RNA and then degrade it, hence decreasing 
the expression of the gene. Attenuation of Hsp70 gene (HSPA1A) expression was achieved 
with three commercial siRNAs (cat. no. 16708; siRNA IDs: 16037, 45023 and 45112, Life 
Technologies, Applied Biosystems, Ambion®, Austin, TX, USA) at two concentrations 
(30nM and 100nM). In addition, negative control siRNA (cat. no. 1022563, Qiagen, Venlo, 
Netherlands), with no homology to any known human gene, was used. The transfections 
of cells were performed with siPORT™Amine transfection reagent (cat. no. AM4502, Life 
Technologies, Applied Biosystems, Ambion®) according to the manufacturer’s 
instructions. The optimal siRNA (siRNA ID 45023) and its concentration (30nM) were 
selected after monitoring the Hsp70 expression levels with Western blotting. 
4.6 ENHANCED GREEN FLUORESCENT PROTEIN (EGFP) -HSP70–
PLASMID CONSTRUCTION AND TRANSFECTION TO ARPE-19 
CELLS 
The mRNA of ARPE-19 cells was reverse transcribed to cDNA and Hsp70 cDNA was 
amplified using Phusion® Hot Start High-Fidelity DNA Polymerase (cat. no. F-540S, 
Thermo Scientific, Finnzymes) following the manufacturer’s instructions. The sequences of 
the oligonucleotide primers used were 5’-ATA CTC GAG ATA TGG CCA AAG CCG C 
(forward) and 5’-AAT AAG CTT GCT AAT CTA CCT CCT CAA TGG TG (reverse), 
containing the target sites for restriction endonucleases XhoI and HindIII, and bases for in-
26 
 
frame ligation (in italics). The sites for initiation and termination of translation are depicted 
in boldface. 
 
The amplified Hsp70 was digested with the above-mentioned restriction enzymes 
(Thermo Scientific, Fermentas) to produce the desired cohesive ends. The multiple cloning 
site of plasmid pEGFP-C1 (Clontech, Mountain View, CA, USA) was also digested with 
the same enzymes. Then the two DNAs were ligated with T4 DNA ligase (Roche, Basel, 
Switzerland) to form a plasmid with fusion gene containing EGFP and HSP70 genes. This 
vector was then transfected into competent DH5α E. coli cells which were prepared using 
the protocol of Inoue et al. (Inoue, Nojima & Okayama 1990). After the propagation and 
purification of the vector (Sambrook 1989), the integrity of the construct was determined 
by restriction endonuclease digestion analysis followed by sequencing of the junction sites 
and the entire inserted Hsp70 open reading frame. 
 
ARPE-19 cells were grown to be 50-70 % confluent before the transfection of the pEGFPh-
Hsp70-plasmid at concentration of 4μg/ml. The transfection was achieved with FuGENE 6 
transfection reagent (Roche) according to the manufacturer’s instructions. The function of 
the construct was initially monitored using RT-PCR amplification of a 365-bp fragment 
over one junction, and by Western blotting, detecting the EGFP-Hsp70 fusion protein. The 
efficacy of the over-expression vector was studied with Western blotting. All the 
exposures to different chemicals were conducted 48 hours after the transfection. 
4.7 CONFOCAL MICROSCOPY 
Confocal microscopy was used to study the localisation of EGFP-Hsp70 and lysosomes in 
pEGFP-Hsp70 transfected cells. The cells were grown on 8-well glass slides (Thermo-
Scientific). The glass slides were treated with collagen type IV (BD Biosciences) before 
plating the cells. The lysosomes were stained with 50nM LysoTracker® Red DND-99 (cat. 
no. L7528, Life Technologies, Invitrogen, Molecular Probes®), for 20 minutes. The cells 
were examined in a Nikon Eclipse TE300 confocal microscope (Nikon). The excitation 
wavelength for EGFP-Hsp70-protein was 488nm and the emission wavelength 525nm. For 
LysoTracker, the wavelengths were 577nm and 590nm. 
4.8 TRANSMISSION ELECTRON MICROSCOPY 
Cell samples were firstly prefixed with 2.5 % glutaraldehyde in 0.1M phosphate buffer 
(pH 7.4) for 2 hours in room temperature followed by postfixing with 1 % osmium 
tetraoxide in 0.1M phosphate buffer (pH 7.4) for 1 hour at room temperature. The samples 
were washed with 0.1M phosphate buffer (pH 7.4, 15min, RT) after both fixations. 
Subsequently the samples were dehydrated with ethanol and embedded in LX-112 resin. 
The polymerisation of resin was carried out at +37 °C for 24h and +60 °C for 48h. The 
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samples were sectioned and examined with transmission electron microscope (JEOL-
1200EX, Jeol, Tokyo, Japan). 
4.9 ELECTROPHORETIC MOBILITY SHIFT ASSAY 
DNA-binding activity of transcription factors (AP-1 and NF-κB) was studied using 
electrophoretic mobility shift assay. Exposed cells were harvested and nuclear proteins 
were extracted: the cytoplasmic proteins were removed to hypotonic buffer (10mM Hepes, 
1.5mM MgCl2, 10mM KCl, 0.2mM PMSF, 1mM DTT) and the intact nuclei were perforated 
with combination of low- and high salt buffer (20mM Hepes, 25 % glycerol, 1.5mM MgCl2, 
20mM KCl, 0.2mM EDTA, 0.2mM PMSF, 1mM DTT and 20mM Hepes, 25 % glycerol, 1.5M 
MgCl2, 1.2mM KCl, 0.2mM EDTA, 0.2mM PMSF, 1mM DTT respectively) in a way that the 
final concentration of KCl was 0.4M. After incubation (30min, 0 °C) and centrifugation (13 
700g, 30min, + 4 °C), the soluble nuclear proteins were collected. Protein concentrations 
were measured using the Bradford-method. 
 
From each sample, five micrograms of nuclear protein with non-radioactive non-specific 
competitor DNA (poly dI/dC) and 32P-radiolabeled specific probe for AP-1 or NF-κB (cat. 
nos. E3201 and E3291 respectively, Promega, Fitchburg, WI, USA) were pipetted into 4.2 % 
native PAGE gel and run for 1h at 180V. Cassettes sensitive to radioactivity were exposed 
to dried gels overnight. The cassettes were scanned in Storm 860 Phosphorimager (GE 
Healtcare) and quantified with ImageQuant 4.2 program (GE Healthcare). 
4.10 PROTEIN CARBONYLS 
Highly reactive free radicals can oxidise many important structures in cells such as 
proteins, lipids and DNA. Protein carbonyls are commonly used markers for protein 
oxidation. These can be measured immunologically and their levels quantified. The 
carbonyl groups of sample proteins were derivatised with dinitrophenylhydrazine and 
measured with ELISA method as previously described (Buss et al. 1997). Two-way 
ANOVA was used to identify differences between control and exposed samples (n=3). 
Differences at certain time points were evaluated by one-way ANOVA, with Bonferroni’s 
multiple-comparison correction.  
4.11 OXYGEN RADICAL ABSORBANCE CAPACITY (ORAC)/TROLOX 
EQUIVALENT ANTIOXIDANT CAPACITY (TEAC) 
The antioxidant capacity of the samples was measured with trolox equivalent antioxidant 
capacity assay. The assay was conducted as described earlier (Kinnunen et al. 2005, Prior 
et al. 2003). Briefly, 2,2′-azobis(2-amidinopropane) dihydrochloride was used as an 
oxidative stressor and fluorescein was used as a target of oxidative stress. Trolox was used 
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as a comparison standard. Oxidative stress is able to convert fluorescent fluorescein into a 
non-fluorescent molecule and this loss of fluorescence can be measured in a fluorometer. 
Statistical differences were evaluated as before in protein carbonyl assay (n=3). 
4.12 LYSOSOME ISOLATION 
The lysosomal fractions of ARPE-19 cells were isolated as previously described (Schutt et 
al. 2002). Briefly, the confluent cells were harvested by trypsination and cell membranes 
were lysed by nitrogen cavitation. The post-nuclear supernatant which contained intact 
cell organelles was obtained after gentle homogenisation and three subsequent low-speed 
centrifugations. The lysosomal fractions were separated with two discontinuous density 
gradient ultracentrifugations. The lysosomal (β-hexosaminidase), mitochondrial (succinate 
dehydrogenase), cytoplasmic (lactate dehydrogenase), plasma membrane (alkaline 
phosphodiesterase), ER and Golgi (UDP-galactosyltransferase), and nuclear (DNA) 
markers were measured to ensure the purity of the lysosomal fractions. Protein 
concentrations were determined by the Lowry procedure (Lowry et al. 1951). 
4.13 SUPEROXIDE DISMUTASE (SOD) ACTIVITY 
Nitroblue tetrazolium (NBT) is a molecule that can oxidise superoxide anion, a highly 
reactive free radical, into O2. In this redox reaction, the colour of NBT changes to become 
purple (NBT-diformazan). Superoxide dismutases are enzymes that protect cells from the 
toxicity caused by superoxide anions by dismutating them to H2O2 and O2. In SOD activity 
assay, xanthine oxidase is used to generate superoxide anions and the formation of purple 
NBT-diformazan from NBT is monitored. The more active superoxide dismutase is 
present in the cells the less NBT-diformazan is formed. The SOD assay was performed as 
previously described (Beauchamp, Fridovich 1971). The amount of reduced NBT was 
measured in a spectrophotometer and statistical evaluation was conducted with Mann-
Whitney U-test (n=5). 
4.14 CALCEIN-AM ASSAY 
Calcein-AM assay was used to determine the efflux protein inhibition capacity of 
geldanamycin and radicicol. Calcein-AM is a non-fluorescent molecule which permeates 
easily through the plasma membrane and once inside the cells it is metabolised to 
fluorescent calcein. Calcein is a substrate for efflux proteins MRP1 and MRP2. If calcein-
AM is co-incubated with efflux protein inhibitors, the amount of fluorescence will be 
increased within the cells. Therefore, an assay of cellular fluorescence reveals the activity 
of efflux proteins and their inhibitors. 
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The assay was performed according to Vellonen et al. (2004). Briefly, the cells were grown 
for four days in 96-well plates before the assay. Then, the medium was changed to the test 
compound (in HBSS, 25mM HEPES, pH 7.4). Calcein-AM was added after 15 minutes of 
incubation in a cell culture incubator. After 20 minutes’ incubation, the solutions were 
removed, HBSS was added and fluorescence was measured (excitation and emission 
wavelengths were 485nm and 550nm, respectively) in a Victor 1420 Multilabel Counter 
(Perkin-Elmer, Waltham, MA, USA). Statistical differences were tested with Mann-
Whitney U-test (n=4). 
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5 Results 
5.1 DIFFERENT STRESS RESPONSES OF ARPE-19 CELLS AFTER 
EXPOSURE TO OXIDATIVE STRESS AND HSP90 INHIBITION 
5.1.1 4-hydroxy-2-nonenal (HNE)-induced oxidative stress (Study I) 
Oxidative stress was induced with HNE, a highly reactive end-product of lipid 
peroxidation. Three different concentrations were used; 5μM, 30μM and 100μM. 
Geldanamycin (GA), at a concentration of 0.25μM was used to inhibit the function of 
Hsp90. This is also known to promote the expression of Hsp70 (Ali et al. 1998, Zou et al. 
1998) which has been shown to confer cytoprotective properties in cells (Garrido et al. 
2003, Kiang, Tsokos 1998). 
 
The levels of Hsp70 were elevated slightly with 5μM of HNE, increasing more with higher 
concentrations. The elevation was observable already at the 6 hour time point and was 
more prominent at the later time points (I Fig. 1). GA on its own increased the expression 
of Hsp70 (I Fig. 1). GA with 5 and 30μM HNE elevated the Hsp70 levels, but interestingly, 
100μM HNE seemed to attenuate the otherwise robust GA-induced Hsp70 response (I Fig. 
1). The amount of Hsp90 was not affected either by HNE or GA (I Fig. 1). 
 
Two transcription factors, activator protein-1 (AP-1) and nuclear factor-κB (NF-κB), 
regulate the expression of many genes in various processes, such as in cellular survival or 
in cellular responses to different stressors (Eferl, Wagner 2003, Pahl 1999). The DNA-
binding activities of AP-1 and NF-κB were determined. No clear trend was seen with AP-1 
in response to HNE and/or GA exposure. Furthermore, 5μM HNE did not have any effect 
on DNA-binding activity of NF-κB but 30 and 100μM concentrations decreased it 
significantly. However, GA together with 5μM HNE, significantly down-regulated NF-κB 
binding but this effect was not anymore seen with higher HNE concentrations (I Fig. 2). 
 
The viability of ARPE-19 cells in response to HNE and GA treatments was studied using 
four different analyses. The morphological investigation revealed the toxic effects of HNE 
at high concentrations (30 and especially 100μM) and those were potentiated by GA (I Fig. 
3). The MTT assay supported these findings (I Fig. 4). GA itself did not cause cellular 
death (I Fig. 4). Apoptotic cells were detected by an ApoTag-kit (I Fig. 5) and their number 
increased substantially with 100μM HNE on its own or with 0.25μM GA combined with 
30 or 100μM HNE (I Fig. 5). These results are in line with the MTT assay. Interestingly, the 
cell death evoked by HNE and GA seemed to be caspase 3-independent (I Fig. 6). 
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5.1.2 The effects of Hsp90 inhibitors on different stress markers and efflux protein 
inhibition capacity (Study II) 
Geldanamycin and radicicol (RA) are both Hsp90 inhibitors. Their effects were compared 
at three different concentrations (0.1, 1 or 5μM) in terms of oxidative stress response, 
cytotoxicity evoked, and their impact on the efflux protein activity. 
 
The protein levels of Hsp90 were not significantly changed in response to Hsp90 
inhibition, although the amount of Hsp90 seemed to decrease slightly in the beginning of 
the exposures (6h samples) (II Fig. 1). Hsp70 was substantially expressed in all Hsp90 
inhibitor-treated cells (II Fig. 1). In addition, the amount of Hsp27 was also increased. 
However, the effect was not as rapid as encountered with Hsp70 (II Fig. 1). The changes in 
heat shock protein levels were practically the identical, irrespective of which inhibitor was 
used (II Fig. 1). 
 
Hsp90 inhibitors had different effects on protein carbonyl levels. Interestingly, RA 
induced the levels of protein carbonyls at both concentrations (0.1 and 5μM) at 24 and 48 
hour time points, while 5μM GA reduced the levels at the 48 hour time point (II Fig. 2A). 
There were no statistical differences in between the samples taken from the cell culture 
medium (II Fig. 2B). Oxygen radical absorbance capacity was also measured. In the 
cellular samples, no differences between samples were detected (II Fig. 3A). In the 
medium samples, both 5μM exposures increased antioxidant levels in similar fashion (II 
Fig. 3B). 
 
Western blots for superoxide dismutase (SOD) did not reveal any significant changes in 
response to GA or RA exposures (II Fig. 4A). Both RA treatments (0.1 and 5μM), but not 
GA, induced HNE protein adducts in ARPE-19 cells (II Fig. 4A). This is in line with the 
data from the protein carbonyl assay (II Fig. 2A). In addition, the SOD activity levels were 
determined. In exposures that lasted 48h, both Hsp90 inhibitors, at both concentrations 
(0.1 and 5μM) evoked a minor increase in SOD activity (II Fig. 2B). 
 
The effects of GA and RA on cellular viability were assessed by a MTT assay. Only 5μM 
GA caused a toxic response in ARPE-19 cells (II Fig. 5). The cell viability was decreased by 
about 20 percentage points. Calcein-AM assay showed that RA, already at 1μM 
concentration, but not GA, has inhibitory effects (~ 30 percentage points) on efflux proteins 
(II Fig. 6). 
5.2 THE FORMATION OF LYSOSOMAL PROTEIN AGGREGATES IN 
RESPONSE TO PROTEASOME INHIBITION (Study III) 
The proteasome inhibitor, MG-132 (10μM) induced the production of protein aggregates 
in ARPE-19 cells (III Fig. 1B, C as well as the first two figures of III Fig. 4A, B and the first 
figure of III Fig. 4C). MG-132 also increased the amounts of Hsp70 and ubiqutinated 
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proteins (III Fig. 1A). Hsp70 and ubiquitin were strongly localised in protein aggregates 
and in the nucleus of MG-132-treated cells (III Fig. 1B, C). Ubiquitin immunostaining was 
most intense in large perinuclear aggregates, whereas Hsp70 was detected in all 
aggregates (III Fig. 1B, C). 
 
The attenuation of Hsp70 was achieved by treatment with siRNAs. The efficacy of the 
siRNA was assessed by Western blotting: the siRNA significantly reduced the expression 
of Hsp70 (III Fig. 2A). The lack of Hsp70 altered the composition of MG-132-induced 
protein aggregates; small dense droplets were observable inside the aggregates (III Fig. 2B 
and the second figure of III Fig. 4C). In addition, the non-specific siRNA affected the 
morphology of aggregates; however, the effect was much more intense with hsp70 siRNA 
(III Fig. 2B). The attenuation of Hsp70 decreased cellular viability in proteasome inhibitor-
treated cells, while the MG-132 on its own did not markedly cause cell death (III Fig. 9). 
 
It was decided to confirm the hypothesis that the MG-132-induced protein aggregates 
would be lysosomal in their nature. Therefore, the association of lysosomal-associated 
membrane proteins, LAMP-1 and LAMP-2, and aggregates were studied. The 
immunostaining analysis revealed that the aggregates were indeed strongly LAMP-2 and 
partially LAMP-1 positive (III Fig. 3A, B, C, D). 
5.3 THE CLEARANCE OF PROTEASOME INHIBITOR-INDUCED 
LYSOSOMAL PROTEIN AGGREGATES (Study III) 
In order to determine whether the formation of lysosomal aggregates would be a 
reversible process, a simple experiment was conducted where the proteasome inhibitor 
was removed after the aggregation took place and the cells were allowed to recover in a 
normal cell culture medium. Phase contrast and transmission electron microscopy 
revealed that the lysosomal protein aggregates disappeared after 24h, at the same time 
autophagosome-like structures were also observable (III Fig. 4A, B and the last figure of III 
Fig. 4C). When the cells were allowed to recover for a further 24h (total of 48h), all the 
protein aggregates and autophagosome-like structures had disappeared (III Fig. 4A, B). 
The formation of aggregates occurred already after 12h of MG-132 treatment, but the 
autophagosome-like structures were could only be seen at 24h, not after 12h of recovery 
(III Fig. 5A).  
 
The cells were also allowed to recover in 10mM NH4Cl which is known to neutralise the 
pH of the lysosomes and thereby inhibiting their function. NH4Cl alone resulted in 
swelling of the lysosomes (III Fig. 4A, B and the third figure of III Fig. 4C). When the 
function of lysosomes was inhibited, the clearance of aggregates and the formation of 
autophagosome-like structures became delayed; effects were not seen until 48h of 
recovery (III Fig. 4A, B). Since NH4Cl is a rather unspecific lysosomal inhibitor, the more 
specific inhibitor, bafilomycin (Baf), was also used. Autophagosome-like structures were 
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formed in response to 100nM Baf (III Fig. 5B). Interestingly, the co-exposure with MG-132 
resulted only in the formation of autophagosome-like structures; no protein aggregates 
were seen with this combination, as seen with MG-132 treatment on its own (III Fig. 5B). In 
the post-treatment with Baf, i.e. after the MG-132 insult, the protein aggregates 
disappeared and only a large number of autophagosome-like structures were seen at all 
time points (III Fig. 5B). 
 
In order to clarify the role of autophagy in the clearance of proteasome inhibitor-induced 
aggregates, the autophagic inhibitor 3-methyladenine (3-MA) was used. The 3-MA 
(10mM) itself had no effect on the morphology of ARPE-19 cells (III Fig. 5C). As expected, 
the aggregates remained when the MG-132-treated cells were allowed to recover in the 
presence of 3-MA, and no autophagosome-like structures appeared. 
 
Hsp70 has a role in the formation of lysosomal aggregates (III Fig. 2B and the second 
figure of III Fig. 4C). Therefore, a green fluorescent protein over-expression vector for 
Hsp70 (EGFP-Hsp70) was created and its efficacy tested (III Fig. 6A). EGFP-Hsp70 
localised strongly in all locations throughout the cells with all exposures (III Fig. 6B, D). 
LysoTracker® was used to determine the quantity and localisation of lysosomes. A larger 
number of lysosomes was detected in the MG-132-pre-treated cells as compared to control 
cells (III Fig. 6B, D). In the 24h-recovery sample, a EGFP-Hsp70 positive early 
autophagosome-like structure was observed merging with the lysosomes (III Fig. 6B, C), 
whereas in the 48h recovery sample EGFP-Hsp70 negative, a late acidic autophagosome-
like structure was seen (III Fig. 6D). 
 
Two more assays were conducted to confirm the association between Hsp70 and 
lysosomal protein aggregates. Confocal microscopy indeed showed a clear co-localisation 
between Hsp70 and the specific lysosomal protein, LAMP-2 in MG-132-treated cells (III 
Fig. 7). In addition, the lysosomes were extracted and an immunoblot against Hsp70 was 
made. The purity of the extracted lysosomes was good (III Table 1). The Hsp70 was once 
more detected in lysosomes of ARPE-19 cells (III Fig. 8). The Hsp70 levels were much 
greater in lysosomes from MG-132-treated cells and in lysosomes extracted from cells that 
had been pre-treated with MG-132 and then allowed to recover in normal cell culture 
medium for 24h (III Fig. 8). In the lysosomes from cells that had been allowed to recover 
for 48h after the MG-132 insult, the levels of Hsp70 had been restored to the control level 
(III Fig. 8). 
5.4 THE INFLUENCE OF TUBULIN ACETYLATION AND HSP90 ON 
PROTEASOME INHIBITOR-INDUCED FORMATION OF 
AGGREGATES AND THEIR CLEARANCE (Study IV) 
Tubulin is deacetylated by an enzyme called histone deacetylase 6 (HDAC6) (Hubbert et 
al. 2002). The chemical paclitaxel (taxol, TAX) hyperstabilises microtubules and prevents 
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the disassembly of microtubule polymers (Buey et al. 2005), whereas nocodazole (NOC) 
depolymerises microtubules (Thyberg, Moskalewski 1999). In order to unravel the role of 
microtubular cytoskeleton and its acetylation in MG-132 (5μM)-induced aggregation and 
in the disappearance of aggregates, TAX (1μM) and NOC (5μM) as well as the HDAC 
inhibitor trichostatin A (TSA, 1μM), were used. The function of Hsp90 in these processes 
was assessed using the Hsp90 inhibitor, geldanamycin (GA, 0.25μM). 
 
Phase contrast and transmission electron microscopy showed that GA inhibited the 
formation of proteasome inhibitor-induced aggregation (IV Fig. 1A, 2A). The TSA and 
NOC seemed to produce similar outcomes in the aggregation process. Aggregates were 
formed but not in the perinuclear space as was the case in cells exposed only to MG-132; 
the aggregates were more evenly dispersed throughout the whole cytoplasm (IV Fig. 1A, 
2A). Co-exposure with TAX and MG-132 resulted in typical perinuclear aggregation (IV 
Fig. 1A, 2A). The MG-132-induced aggregates were cleared from cells in the same manner 
irrespective of whether GA, TSA, TAX or NOC were present in the recovery medium (IV 
Fig. 1B, 2B). 
 
The levels of ubiquitin, Hsp90, Hsp70 and acetylated tubulin were measured by Western 
blotting. The amount of ubiquitin protein conjugates was increased by all MG-132 
exposures and did not return to the basal level in any recovery samples (IV Fig. 3A, B). 
The expression of Hsp90 was slightly upregulated after all MG-132 and GA treatments (IV 
Fig. 3A, B). The response of Hsp70 to the treatments was much more dramatic; the amount 
of Hsp70 was many times greater in all MG-132 and GA exposures (IV Fig. 3A, B). TAX or 
NOC did not have notable effect on the Hsp90 or Hsp70 levels. Whereas the effect of TSA 
on Hsp90 levels was similar to TAX and NOC, the amount of Hsp70 was roughly tripled 
in TSA exposure when compared to control (IV Fig. 3A, B). As anticipated, TSA greatly 
increased (~ 4 x control) the acetylation of tubulin and NOC decreased (~ 1/10 of control) 
the amount of acetylation while the other compounds had no effect (IV Fig. 3A, B). 
 
The level of autophagosomal induction marker, LC3 (LC3-II and LC3-II/I) was also 
examined with GA treatments at different time points because it has been shown that 
inhibition of Hsp90 can induce autophagy (Finn et al. 2005, Riedel et al. 2010). According 
to the present studies, MG-132 could stimulate autophagy to some extent. In contrast, GA, 
with or without MG-132, had no apparent effect (IV Fig. 4A, B). 
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6 Discussion 
RPE cells are crucial for the well-being of photoreceptors (Sparrow, Hicks & Hamel 2010). 
Due to their function and location, the post-mitotic RPE cells are constantly being exposed 
to severe oxidative stress (Beatty et al. 2000). In combination with other endo- and 
exogenous stressors, it eventually causes cellular impairments e.g. in the Hsp response 
and proteolysis. This in turn leads to the formation of protein aggregates (Anderson et al. 
2002, Gehrs et al. 2006). Although the mechanisms accounting for the formation of intra- 
and extracellular protein aggregates are still largely unknown, the number of these 
structures is known to correlate well with the severity of AMD. 
 
This series of studies was conducted using ARPE-19 cell line. While there are some 
differences between ARPE-19 and primary RPE cells, they are rather similar with each 
other (Alge et al. 2006, Dunn et al. 1996, Dunn et al. 1998, Finnemann et al. 1997, Liao, 
Turko 2009, Mannermaa et al. 2009). This cell line was selected due to its popularity as an 
RPE cell model and because it is widely used in research focused on in vitro retinal disease 
models, including AMD. It is also more convenient to perform this kind of large set of 
studies with cell line at first; to screen the results before going to more complicated 
models. Because this study concentrates on several processes in rather general level, one 
can quite safely assume that the results presented here apply relatively well, also, to 
primary RPE cells. The mechanisms studied, such as Hsp response, protein degradation 
and aggregation, are basic cellular functions in all cells, including RPE cells (Kaarniranta et 
al. 2009, Roth, Bindewald & Holz 2004). 
6.1 HNE AND HSP90 INHIBITOR-INDUCED STRESS RESPONSES IN 
HUMAN RPE CELLS 
6.1.1 HNE-induced stress is increased by the Hsp90 inhibitor geldanamycin in 
human RPE cells 
In the retina, the lipid-rich photoreceptor outer layer is constantly exposed to oxidative 
stress. When lipids are oxidised, highly reactive end-products, such as HNE, are formed. 
At lower concentrations, HNE has been proven to be beneficial to cells, but in excess, it has 
been linked to AMD, as well as many other pathological disorders (Kopitz et al. 2004, Poli 
et al. 2008). 
 
The Hsp90 inhibitor, geldanamycin, is known to offer protective effects as demonstrated 
in several models of protein aggregation diseases, such as amyotrophic lateral sclerosis 
(Batulan et al. 2006), Huntington’s (Sittler et al. 2001) and Parkinson’s diseases (Auluck, 
Meulener & Bonini 2005, Shen et al. 2005). Cytoprotection is also seen for example in 
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cerebral ischemia (Kwon et al. 2008, Lu et al. 2002) and protein phosphatase inhibitor-
treated human RPE cells (Kaarniranta et al. 2005). The cytoprotection is believed to be 
mediated through the induction of the Hsp response (especially Hsp70 and Hsp40); when 
geldanamycin binds to Hsp90 inhibiting its function, it simultaneously releases HSF1 from 
the same complex and this triggers the expression of Hsps (Ali et al. 1998, Stebbins et al. 
1997, Whitesell et al. 1994, Zou et al. 1998). On the other hand, the cytotoxicity of Hsp90 
inhibitors, especially geldanamycin is well known (Dey, Cederbaum 2007, Supko et al. 
1995, Wu et al. 2009). 
 
It was demonstrated in paper I that HNE could increase Hsp70 levels and evoke cellular 
death in ARPE-19 cells. In contrast to previous findings, where HNE caused caspase 3-
mediated apoptotic cell death in neuronal cells (Rabacchi et al. 2004), in ARPE-19 cells the 
HNE-induced apoptotic cell death was caspase 3-independent. Hsp70 is an important 
chaperone molecule, which has the ability to normalise many stressful conditions and 
refold stress-induced denatured proteins and therefore promote cellular survival. The two 
lower HNE concentrations used (5μM and 30μM) increased the Hsp70 levels, but did not 
exert any clear cytotoxic effects, whereas 100μM HNE caused massive decline in cellular 
viability. It has been previously shown that Hsps can reduce the oxidative cellular damage 
(Park et al. 1998, Su et al. 1999, Yamamoto et al. 2000). With the lower concentrations of 
HNE, Hsp70 may still have the capability to protect the cells from oxidative damage. The 
Hsp70 levels were intensified even more during co-exposure with geldanamycin, 
however, this resulted in more extensive cell death, which was not seen at all in cells 
treated with geldanamycin alone. The increased cell death seen with HNE and 
geldanamycin may be a result of a reduction in glutathione supply; HNE is partly 
metabolised via glutathione S-transferase (Choudhary et al. 2005, Xie, Lovell & 
Markesbery 1998) and geldanamycin is known to be able to deplete the glutathione supply 
(Clark et al. 2009). The results here imply that HNE-induced stress response is regulated in 
ARPE-19 cells, at least partially, with the help of Hsp70 and Hsp90 molecular chaperones. 
 
There are several studies revealing that the activity of the stress marker AP-1 is increased 
in HNE-induced oxidative stress, whereas NF-κB activity does not change or even 
decreases (Camandola et al. 1997, Camandola, Poli & Mattson 2000b, Kikuta et al. 2004, 
Kutuk, Basaga 2007, Uchida et al. 1999). In ARPE-19 cells, no clear trend was seen in the 
DNA-binding activity of AP-1. In one study, the HNE-induced increase in DNA-binding 
activity of AP-1 has been demonstrated to be mediated via caspases (Camandola, Poli & 
Mattson 2000a), whereas in ARPE-19 cells, at least the caspase 3 levels remained at the 
basal level. The activity of the transcription factor NF-κB was decreased in response to 
HNE exposures. It is known that HNE acts as an inhibitor of NF-κB by preventing the 
activation of IκB kinase, thus preventing IκB phosphorylation and dissociation from NF-
κB (Ji, Kozak & Marnett 2001, Nakashima et al. 2003, Page et al. 1999). Geldanamycin 
potentiated the effect of HNE on NF-κB; a clear reduction in the DNA-binding activity of 
NF-κB was seen during co-exposure with 5μM HNE. It has been shown that Hsp70 can 
prevent the function of IκB kinase and thus inhibit the activation of NF-κB (Agou et al. 
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2002, Paimela et al. 2011, Ran et al. 2004, Weiss et al. 2007). In addition, Hsp90 is needed in 
the functional IκB kinase complex (Chen, Cao & Goeddel 2002). Therefore, geldanamycin, 
which increases the amount of Hsp70 and inhibits the function of Hsp90, decreases the 
levels of the active form of NF-κB. Similar results with geldanamycin have also been seen 
with other cell types (Broemer, Krappmann & Scheidereit 2004, Chen, Cao & Goeddel 
2002, Pittet et al. 2005). The reason that the effect was not seen anymore in co-exposures 
with higher HNE concentrations could be due to the already vast effect of the HNE itself. 
In addition, the induction of Hsp70 levels in response to Hsp90 inhibition seemed to be the 
most effective with the lowest HNE concentration, which was probably because the 
treatments were starting to inflict significant cell death. Geldanamycin-induced decrease 
in NF-κB signalling could attenuate the NF-κB-induced cellular survival responses. These 
differences between the results presented in paper I and previous studies are probably due 
to cell-type specific differences, which have also been reported before; in some cells the 
NF-κB activities have increased after HNE insults (Malone, Hernandez 2007, Ruef et al. 
2001). 
6.1.2 The Hsp90 inhibitor, the non-quinone radicicol, seems to cause oxidative stress 
on human RPE cells, whereas the quinone geldanamycin is not active in this 
way 
In study II, two common Hsp90 inhibitors, geldanamycin and radicicol, were studied in 
human RPE cells. The toxicity of geldanamycin is believed to be linked to the production 
of ROSs, via the quinone group of geldanamycin, whereas radicicol lacks this quinone 
group (Billecke et al. 2002, Dey, Cederbaum 2006, Dikalov, Landmesser & Harrison 2002, 
Sreedhar et al. 2003). In line with previous studies, both Hsp90 inhibitors greatly induced 
Hsp70 levels. In addition, Hsp27 levels were also increased. It seems that the Hsp 
induction is similar with both geldanamycin and radicicol. Rather surprisingly, the 
oxidative stress markers, protein carbonyls and HNE adducts, were increased only by the 
radicicol treatment. The oxygen radical absorbance capacity and activity of superoxide 
dismutase (SOD) were slightly elevated after exposures to either of these Hsp90 inhibitors, 
but no change in the actual amounts of SOD was detected. These results imply that the 
quinone group in the Hsp90 inhibitor is not critical in determining the magnitude of Hsp- 
or oxidative stress response in human RPE cells. Although radicicol somewhat increased 
oxidative stress and geldanamycin did not, geldanamycin was more toxic. This indicates 
that the cytotoxicity of Hsp90 inhibitors is, at least partially, independent of oxidative 
stress in human RPE cells. Indeed, it has been later claimed that the cytotoxicity of 
geldanamycin is also mediated through glutathione depletion (Clark et al. 2009). 
 
Hsp90 inhibitors have been widely investigated as potential anti-cancer drugs (Porter, 
Fritz & Depew 2010, Richardson et al. 2011b). One of the main reasons for apparently 
promising drugs being ineffective in clinical use is the efflux-protein-pump system, where 
certain proteins actively transport the otherwise effective drug out of the cells (Bansal et al. 
2009, Mannermaa, Vellonen & Urtti 2006, O'Connor 2009). Efflux proteins create drug 
delivery issues in various diseases and tissues, especially in brain (blood-brain barrier) 
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and retina (blood-retinal barrier). In an attempt to overcome these problems, many 
different efflux-protein inhibitors are being developed and investigated (Baumert, 
Hilgeroth 2009, Pages, Amaral 2009). In ARPE-19 cells, radicicol did inhibit efflux proteins 
to some extent, but geldanamycin had no effect. Previous studies have shown that efflux 
proteins protect cells from oxidative stress (Fantappie et al. 2004, Sun et al. 2006, 
Takahashi et al. 2009, Thevenod et al. 2000). The ability of radicicol to inhibit efflux 
proteins might be one of the reasons why radicicol caused more oxidative stress than 
geldanamycin. These results show that these two Hsp90 inhibitors have distinct 
characteristics, i.e. while they share similar properties in human RPE cells, they can also 
exert mutually distinct effects. 
6.2 HSP70 REGULATES PROTEASOME INHIBITOR-INDUCED 
FORMATION OF HSP70 AND UBIQUITIN POSITIVE AGGREGATES 
The effects of proteasome inhibition were examined in ARPE-19 cells: similar increase was 
found in the levels of Hsp70 and ubiquitin-protein conjugates, as observed in the previous 
studies on other cell types (Bush, Goldberg & Nigam 1997, Kawazoe et al. 1998, Kim, Kim 
& Li 1999, Zhou, Wu & Ginsberg 1996). Both Hsp70 and ubiquitin conjugates co-localised 
strongly with the formed juxtanuclear protein aggregates in ARPE-19 cells. It has been 
shown earlier that similar aggregates also contain other molecular chaperones, such as 
Hsc70 and Hsp40 (Garcia-Mata et al. 1999). When the proteasomes fail in their task, 
misfolded proteins start to accumulate and this triggers the Hsp response. Efficient 
removal of misfolded proteins is important for cellular well-being (Saibil 2008, Vabulas et 
al. 2010). If the Hsps are unsuccessful, the misfolded proteins aggregate and eventually 
form large aggresomes in the perinuclear space via dynein-dependent trafficking through 
the microtubule network (Iwata et al. 2005b, Kopito 2000, Kopito 2003). A robust increase 
was also seen in the amount of Hsp70 inside the nucleus. This suggests that Hsp70 may 
have chaperonal functions also in that location, in addition to its autoregulatory role with 
HSF1 (Abravaya et al. 1992). 
 
Hsp70 evidently regulates the formation of proteasome inhibitor-induced aggregates 
because their structure became altered as a consequence of the inhibition of Hsp70 
expression achieved by the RNAi technique. The attenuation of Hsp70 also decreased the 
cellular viability indicating its cytoprotective properties. 
6.3 PROTEASOME INHIBITOR-INDUCED LYSOSOMAL AGGREGATES 
ARE REMOVED VIA AUTOPHAGIC DEGRADATION WITH THE HELP 
OF INDUCIBLE HSP70 
The proteasome inhibitor-induced aggregates detected in ARPE-19 cells were confirmed to 
be lysosomal as they were undoubtedly positive for two lysosomal-associated membrane 
proteins, LAMP-1 and LAMP-2. This implies that lysosomal/autophagosomal degradation 
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has a role in the clearance of these aggregates. Indeed, the autophagosomal structures 
were visualised with transmission electron and confocal microscopy, when the 
proteasome inhibition was removed and the cells were allowed to recover in normal cell 
culture medium. At the same time the number of aggregates diminished. 
 
The lysosomal degradation could be disturbed by NH4Cl and bafilomycin. NH4Cl elevates 
the pH of lysosomes in a non-specific manner and inhibits their function, whereas 
bafilomycin blocks the V-ATPase on the surface of lysosomes, preventing the acidification 
process and therefore organelle function (Jurkovitz et al. 1992, Lacave et al. 1999, 
Yamamoto et al. 1998). It has been postulated that the increase in the pH of acidic 
compartments, such as lysosomes, also inhibits the fusion of lysosomes with 
autophagosomes (Kawai et al. 2007). Both chemicals slowed down the aggregate removal 
and increased the formation of autophagosomes. The number of autophagosomes was 
increased probably due to complementary mechanisms; the cells may attempt to 
compensate for the poor quality of the autophagosomes by increasing their quantity. 3-
MA was used to inhibit autophagic degradation in more specific manner. As predicted, 
this also resulted in inefficient aggregate clearance. These results consolidate the 
conclusion that the proteasome inhibitor-induced protein aggregates are removed via the 
autophagic system in human RPE cells. 
 
The connection between Hsp70 and proteasome inhibitor-induced lysosomal protein 
aggregates was examined in more detail. As seen previously, the specific lysosomal 
protein LAMP-2 was clearly induced in MG-132-treated ARPE-19 cells, and these 
lysosomes were strongly localised with the aggregates. When studying the localisation of 
Hsp70 and LAMP-2, the LAMP-2 was always detected together with the Hsp70 in 
response to proteasome inhibition. Lysosomes were also isolated from exposed cells and 
examined for the presence of Hsp70. While only small amount of Hsp70 was observed in 
lysosomes of control cells, in proteasome inhibitor-treated cells the level of lysosomal 
Hsp70 was greatly elevated as was the case in the cells that were allowed to recover in 
normal cell culture medium for 24h after the MG-132 insult. This is the time point where 
the manifestation of autophagosomes was most evident. In the lysosomes of the MG-132 
exposed cells that were allowed to recover for 48h, the degree of Hsp70 had returned to 
the basal level, and at this time point also all of the aggregates and autophagosomes had 
disappeared; the lysosomal Hsp70 appears to follow the aggregates and autophagosomes. 
This data proves that Hsp70 is present inside the lysosomes and in proteasome inhibitor-
induced lysosomal aggregates in ARPE-19 cells. The constitutive Hsp70 (Hsc70) has been 
shown earlier to be found inside the lysosomes (Agarraberes, Terlecky & Dice 1997) and 
today its role in chaperone-mediated autophagy is well known (Li, Yang & Mao 2011). 
This present study indicates that the inducible Hsp70 might be an important regulator of 
macroautophagic degradation. 
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6.4 HSP90, TUBULIN ACETYLATION AND TUBULIN POLYMERISATION 
REGULATE THE FORMATION OF PROTEASOME INHIBITOR-
INDUCED PERINUCLEAR AGGREGATES, BUT NOT THE 
AUTOPHAGIC DEGRADATION OF AGGREGATES 
Small protein aggregates are delivered along microtubules to the perinuclear space where 
they form large aggresomes (Kawaguchi et al. 2003, Kopito 2003). The acetylation level of 
tubulin plays a role in the function of microtubule network (Hubbert et al. 2002, 
Matsuyama et al. 2002), whereas its role in the stability of microtubule network is more 
controversial (Haggarty et al. 2003, Hubbert et al. 2002, Loktev et al. 2008, Matsuyama et 
al. 2002, Palazzo, Ackerman & Gundersen 2003). The acetylation of tubulin, with histone 
deacetylase (HDAC) inhibitors, has been observed to increase microtubule-dependent 
trafficking in both anterograde and retrograde directions (Dompierre et al. 2007, Reed et 
al. 2006). On the other hand, it has been demonstrated that HDAC6 is needed to transport 
aggregates so that they can form aggresomes (Kawaguchi et al. 2003). Overall, it seems 
that the consequences of tubulin acetylation in cells are enigmatic. In this study, it was 
demonstrated that the histone decacetylase inhibitor, trichostatin A (TSA) affected the 
localisation of the proteasome inhibitor-induced aggregates; they were dispersed evenly 
throughout the cytoplasm, whereas normally they were located in perinuclear space. On 
the other hand, acetylation of Hsp90 inhibits its function, and HDAC6 is the enzyme that 
deacetylates Hsp90 (Kovacs et al. 2005b, Scroggins et al. 2007). By inhibiting histone 
deacetylases with TSA, one could speculate that Hsp90 would probably be left in an 
acetylated, non-functional state (see next chapter). The same end-result observed with TSA 
happened also after treatment with a microtubule-depolymerising agent nocodazole. This 
indicates that microtubules per se are necessary for normal aggregation to occur, and 
HDAC6 as well as the acetylation of tubulin are also probably linked to this process. 
 
The Hsp90 inhibitor prevented proteasome inhibitor-induced aggregation. The role of 
Hsp90 in movement toward the nucleus, via the microtubule network and dynein motor, 
has been elucidated in some Hsp90 client proteins (Czar et al. 1997, Galigniana et al. 1998, 
Galigniana et al. 2004, Georget et al. 2002). It has also been demonstrated that Hsp90 
inhibition can reduce the formation of huntingtin aggregates (Sittler et al. 2001) and 
mutant androgen receptor aggregates (Thomas et al. 2004). In previous studies, Hsp90 
inhibition was reported to induce autophagy (Finn et al. 2005, Riedel et al. 2010) and this 
could also be one of the reasons for prevention of aggregation by Hsp90 inhibition. 
However, no autophagic induction was seen in human RPE cells in response to Hsp90 
inhibition. The data from study IV imply that misfolded proteins/small aggregates are 
clients for Hsp90 and that Hsp90 is an essential molecule regulating the retrograde 
trafficking of these denatured proteins/small aggregates to a distinct location, where they 
form large deposits. Hsp90 greatly induced the expression of Hsp70. In study III, it was 
demonstrated that Hsp70 has cytoprotective effects in proteasome inhibitor-treated ARPE-
19 cells. The significant induction of molecular chaperone Hsp70 in response to Hsp90 
inhibition might also reduce the formation of protein aggregates (Sittler et al. 2001, 
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Thomas et al. 2004). However, this was probably not that important in this particular 
experiment because it seemed that MG-132 already was able to evoke maximal Hsp70 
expression. On the other hand, Sittler (et al. 2001) also demonstrated that the induction of 
Hsp40 in response to Hsp90 inhibition was important as well in the inhibition of 
huntingtin aggregation. The role of Hsp40 in protein aggregation of human RPE cells 
remains to be elucidated. 
 
Hsp90, HDAC inhibition/tubulin acetylation or, rather surprisingly, polymerisation of 
microtubules did not affect the clearance of protein aggregates in ARPE-19 cells. There is 
definite connection between autophagy and microtubules. However, the exact role of 
microtubules in autophagy is a bit controversial (Fass et al. 2006, Fengsrud et al. 1995, 
Iwata et al. 2005, Jahreiss, Menzies & Rubinsztein 2008, Kimura, Noda & Yoshimori 2008, 
Kochl et al. 2006). The most common hypothesis is probably that autophagosomes uses 
dynein motor and microtubule network to deliver material to be degraded from the 
cytosol to lysosomes (Fass et al. 2006, Jahreiss, Menzies & Rubinsztein 2008, Kimura, Noda 
& Yoshimori 2008, Ravikumar et al. 2005). However, one of these studies has shown that 
an intact microtubule network is not obligatory for autophagosomal degradation (Fass et 
al. 2006). The data presented in paper IV supports the finding that an intact microtubule 
network is not needed for successful autophagosomal degradation. 
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7 Summary and Conclusions 
Age-related macular degeneration (AMD) is a progressive and severe eye disease, where 
the well-being of retinal pigment epithelial cells plays an essential role (Fig. 5). When 
environmental and intrinsic stressors and other detrimental factors such as continual 
oxidative stress and genomic-based traits, overwhelm the protective systems present in 
RPE cells, then the harmful effects starts to appear also in photoreceptors, and eventually 
resulting defects in vision. One of the most important detrimental changes in RPE cells 
and in retina is the accumulation of various types of protein aggregates. Aggregation, 
oxidative stress and protective heat shock proteins were studied in a simple cell culture 
model of AMD. 
 
Molecular chaperones Hsp90 and Hsp70 seemed to be regulators of lipid-peroxidation 
product 4-hydroxy-2-nonenal (HNE)-induced stress response in human retinal pigment 
epithelial (RPE) cells. When comparing the effects of the two Hsp90 inhibitors, the 
quinone, geldanamycin and the non-quinone, radicicol, in RPE cells, it was observed that 
the oxidative stress was not dependent on the presence of quinone structure in the 
inhibitor, and the toxicity of geldanamycin did not appear to be attributable to oxidative 
stress. Although the heat shock protein responses seem to be similar for these two Hsp90 
inhibitors, there are also differences in their responses, for example in the oxidative stress 
they evoke. This information might help to develop better Hsp90 inhibitors and their 
derivatives, which in the future may be used to treat severe diseases such as age-related 
macular degeneration. 
 
The proteasome inhibitor-induced protein aggregates formed in the perinuclear space 
were positive for Hsp70 and ubiquitin, and were undoubtedly lysosomal-based. Hsp90 is 
a very important factor in the aggregation; without it, no aggregates can be formed. In 
addition, Hsp70 is one of the regulators of the aggregation process; abrogation of Hsp70 
resulted in a more granular appearance of the aggregates. Treatment with a microtubule 
depolymerising agent did not prevent the aggregate formation but they were not 
trafficked to the perinuclear space, i.e. an intact microtubule network is needed for the 
normal aggregation. A similar end result could be obtained by acetylating microtubules; 
however, the concurrent acetylation of Hsp90 may have also influenced the aggregation. 
 
Non-senescent RPE cells have the ability to remove harmful aggregates achieved via 
autophagic degradation. It also seems that Hsp70 has a role in the clearance of aggregates, 
whereas Hsp90 and the acetylation of microtubules and Hsp90 appear to be insignificant 
contributors. Interestingly, also a disruption of the microtubule network had no effect on 
the clearance of the aggregates. 
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Taken together, these results reveal the importance of certain heat shock proteins in cell 
survival, protein aggregation and the clearance of aggregates. In addition, it is essential to 
know that the RPE cells have the ability to remove aggregates, and the specific mechanism 
for it, in order to discover new possible treatments to prevent the protein aggregation 
which has been identified as a major contributor in many age-related, degenerative 
disorders, such as age-related macular degeneration. 
 
Based on here presented, as well as previous and later studies, a schematic hypothesis of 
the formation of various types of protein aggregates in aging RPE cells is presented in the 
Figure 5. 
 
 
Figure 5. Protein aggregation in aged RPE cells. RPE cells are exposed to oxidative stress and 
inflammation from several sources. RPE cells phagocytose POS and degrade them in 
lysosomes. In senescent RPE cells, this mechanism is impaired leading to lipofuscin formation, 
increased oxidative stress and further protein damage. The refolding of damaged proteins by 
heat shock proteins is unsuccessful in aged cells, also the proteolytic ubiquitin-proteasome and 
autophagic systems are not fully functional. This forms the basis for the protein aggregation 
and since the accumulated material cannot be degraded, it is suggested to be transported out 
of the cells and might be involved in the formation of drusen. The scheme is modified from 
Kaarniranta et al. (2010). 
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Henceforth, our goal is to broaden the knowledge in the field of protein aggregation and 
their degradation mechanisms. As a continuum to this study, the next step might be the 
start of protein aggregation experiments with primary RPE cells. In addition, other 
models, such as differentiated ARPE-19 cells, prematurely senescent ARPE-19 cells and 
laboratory animals, may be required in future experiments. While utilising these models 
might be challenging, they are needed to consolidate the results presented here and they 
will also assist in learning more about these essential processes. 
 
To date, the treatment possibilities for AMD are limited to the anti-VEGF therapies in 
exudative AMD. One of the biggest challenges is to discover therapies also to atrophic 
form of AMD, which comprises most of AMD cases. It must be noticed that AMD in 
particular is a disease in which the protein aggregation plays an important role. Therefore, 
it is crucial to know more on protein aggregation and be aware of the mechanisms cells 
fight against aggregated proteins. This study reveals the clearance mechanism of protein 
aggregates in RPE cells. This might provide new pharmaceutical target to improve cellular 
survival of RPE cells. The future will show if it is possible to ease the burden of RPE cells 
under unfavourable conditions linked to AMD by, for example, upregulating specific heat 
shock proteins, ubiquitin-proteasome system and autophagy. 
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Age-related macular degeneration 
(AMD) is the most common reason 
for visual impairment in western 
countries. Retinal pigment epithelial 
cells (RPE) and extra- and intracellu-
lar protein aggregation play a crucial 
role in the development of this dis-
ease. The main focus of this study 
was the formation of protein aggre-
gates and their removal in RPE cells. 
This thesis contributes to the overall 
knowledge on the function of RPE 
cells and provides a new possible 
target for designing novel therapies 
against AMD.
